Document:

Exhibit 10.8 

 

SUPPORT SERVICES AGREEMENT

 

This
Support Services Agreement (this “Agreement”), dated as of [·],
2021, is made and entered into by and between Banyan Acquisition Corporation, a Delaware corporation (the “Company”),
and H&J SPAC Investors LLC, a Delaware limited liability company (the “Service Provider” and, together with the
Company, the “Parties” and, each individually, a “Party”).

 

RECITALS

 

WHEREAS, the Company intends
to consummate an initial public offering of the Company’s securities (the “Public Offering”);

 

WHEREAS, the Company was formed
for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (a “Business Combination”); and

 

WHEREAS,
the Company wishes to retain the Service Provider to provide certain support and administrative services, and provide access to certain
office space, commencing on the date the securities of the Company are first listed on the New York Stock Exchange (the “Listing
Date”) and continuing until the earlier of the consummation by the Company of an initial Business Combination and the Company’s
liquidation (in each case, as described in the Registration Statement on Form S-1 (File No. 333-[·])
filed with the Securities and Exchange Commission related to the Public Offering) (such earlier date hereinafter referred to as the “Termination
Date”).

 

NOW, THEREFORE, in consideration
of the mutual covenants and undertakings contained in this Agreement, the Company and the Service Provider, intending to be legally bound,
agree as follows:

 

ARTICLE I

 

SERVICES

 

Section 1.1        Services
Generally. Commencing on the Listing Date and continuing until the Termination Date, to the extent reasonably requested by the Company,
the Service Provider shall render to the Company, by and through such of the Service Provider’s officers, employees, independent
contractors, consultants, agents, representatives and affiliates as the Service Provider, in its sole discretion, may designate from time
to time, support and administrative services (collectively, the “Services”), including research, due diligence, transaction
process management and execution, information technology, public and investor relations, legal, facilities management, back office, vendor
management, accounting, book and record keeping, cash management, secretarial services and other services in connection with identifying
and evaluating potential initial Business Combination targets that the Service Provider may recommend to the Company; provided that
the Service Provider shall not provide any investment advice to the Company.

 

Section 1.2        Office
Space. Commencing on the Listing Date and continuing until the Termination Date, to the extent reasonably requested by the Company,
the Service Provider shall provide the Company with access to, and use of, the Office Space. For the purposes of this Agreement, the term
 “Office Space” shall mean the offices of the Service Provider located at 400 Skokie Blvd, Suite 820, Northbrook, Illinois
60062 (or any successor location or other existing office space of the Service Provider or any of its affiliates).

 

     

     

    

 

Section 1.3         No
Authority to Bind Principal. Notwithstanding any provision to the contrary in this Agreement, the Service Provider shall not represent
to any party that it possesses, and it does not in fact possess, the authority to execute binding contracts on behalf of the Company with
any third party.

 

ARTICLE II

 

SERVICE FEE

 

Section 2.1        Support
Services Fee.

 

(a)            In
consideration of the performance of the Services contemplated by Section 1.1 hereof, the Company agrees to pay the Service
Provider or its designee(s) a monthly fee payable in cash equal to $10,000 (the “Support Services Fee”). The Support
Services Fee shall be payable by the Company monthly in advance on the first business day of each month that occurs following the Listing
Date until the Termination Date, without regard to the amount of the Services actually performed by the Service Provider. Notwithstanding
anything to the contrary, the first monthly installment of the Support Services Fee shall be payable by the Company in advance on the
Listing Date, instead of on the first business day of the first month that occurs following the Listing Date.

 

Section 2.2        Expenses.
In addition to the Support Services Fee payable to the Service Provider or its designee(s) pursuant to Section 2.1 here
of, the Company shall, at the direction of the Service Provider, pay directly, or reimburse the Service Provider or its designee(s) for,
its reasonable Out-of-Pocket Expenses (as defined below). For the purposes of this Agreement, the term “Out-of-Pocket Expenses”
shall mean all out of pocket expenses incurred by the Service Provider or its respective affiliates in connection with the performance
of the Services, or providing access to, and use of, the Office Space, including (i) fees and disbursements of any independent auditors,
outside legal counsel consultants, investment bankers, financial advisors and other independent professionals and organizations, (ii) costs
of any outside services or independent contractors or vendors, such as financial printers, couriers, business publications or similar
services, (iii) transportation and other travel expenses, per diem, telephone calls, word processing expenses or any similar expense
not associated with its ordinary operations, (iv) other out-of-pocket expenses incurred by the Service Provider to the extent reasonably
allocated to the Company as a result of the Services in a manner consistent with the Service Provider’s generally applicable cost
allocation polices, including purchases through the Service Provider’s vendor networks and relationships for access to research
databases, due diligence services, computer, network and office equipment and third-party communications vendors, and (v) all other
expenses which are properly allocable to the Company under this Agreement, whether incurred on or after the date of this Agreement. All
reimbursements for Out-of-Pocket Expenses shall be made promptly upon or as soon as practicable after presentation by the Service Provider
to the Company of the statement in connection therewith.

 

    2 

     

    

 

Section 2.3        Any
payment made pursuant to this Article II shall be paid by wire transfer of immediately available federal funds to the accounts
specified by the Service Provider from time to time.

 

ARTICLE III

 

WAIVER

 

Section 3.1        Waiver.
Notwithstanding anything herein to the contrary, the Service Provider hereby irrevocably waives any and all right, title, interest, causes
of action and claims of any kind as a result of, or arising out of, this Agreement (each, a “Claim”) in or to, and
any and all right to seek payment of any amounts due to it out of, the trust account established for the benefit of the public shareholders
of the Company and into which substantially all of the proceeds of the Public Offering will be deposited (the “Trust Account”),
and hereby irrevocably waives any Claim it may have in the future as a result of, or arising out of, this Agreement, which Claim would
reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees
not to seek recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or other assets in the
Trust Account for any reason whatsoever.

 

ARTICLE IV

 

CONFIDENTIAL INFORMATION

 

Section 4.1        Nondisclosure
of Confidential Information. The Service Provider shall treat as confidential all Confidential Information (as defined below) of the
Company, shall not, without the consent of the Company, (i) use such Confidential Information except as set forth herein or (ii) disclose
such Confidential Information other than to the Company or its Related Parties (as defined below); provided that each such person
receiving Confidential Information is bound (on terms no less restrictive than those set forth in this Section 4.1) to maintain
the confidentiality of such Confidential Information; provided, further, that the foregoing restriction shall not apply to any
such information that is required to be disclosed by law or the order or regulations of any governmental authority or to establish or
enforce any rights under this Agreement. Without limiting the foregoing, the Service Provider shall use at least the same degree of care
that it uses to prevent the disclosure of its own confidential information of like importance to prevent the disclosure of Confidential
Information disclosed to it by the Company under this Agreement. For the purposes of this Agreement, the term “Confidential Information”
shall mean all information, data, agreements, letters, documents, reports and records, which are oral or in writing, containing confidential
information concerning the Company and any of its affiliates or assets which is delivered or made available by the Company or its representatives
or affiliates to the Service Provider after the date hereof; provided that Confidential Information does not include (x) information
which is obtained by the Service Provider after the date hereof from a source other than the Company or its representatives or affiliates
that is not bound by an obligation to keep such information confidential, (y) information which is or becomes generally available
to the public other than as a result of a disclosure in violation of this Agreement, or (z) information developed independently by
the Service Provider without reference to or use of the Confidential Information.

 

    3 

     

    

 

ARTICLE V

 

INDEMNIFICATION; DISCLAIMER AND LIMITATION OF
LIABILITY; OPPORTUNITIES.

 

Section 5.1        Indemnity
and Liability. Subject to Section 3.1, the Company shall (i) indemnify, exonerate and hold the Service Provider and
each of its partners, shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling persons, employees, independent
contractors and agents and each of the partners, shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling
persons, employees, independent contractors and agents of each of the foregoing (collectively, the “Related Parties”)
free and harmless from and against any and all actions, causes of action, suits, claims, liabilities, losses, damages and costs and out-of-pocket
expenses in connection therewith (including attorneys’ fees and expenses) incurred by the Related Parties or any of them before
or after the date of this Agreement (collectively, the “Indemnified Liabilities”), arising out of any action, cause
of action, suit, arbitration, investigation or claim arising out of, or in any way relating to, (i) this Agreement, any transaction
to which the Company is a party or any other circumstances with respect to the Company or (ii) the operations of, or the Services
or Office Space provided by the Service Provider to, the Company, or any of its affiliates from time to time; provided, however, that
the foregoing indemnification rights will not be available to the extent that any such Indemnified Liabilities arose on account of such
Indemnitee’s gross negligence or willful misconduct; and provided, further, that if and to the extent that the foregoing
undertaking may be unavailable or unenforceable for any reason, the Company hereby agrees to make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. For purposes of this Section 5.1,
none of the circumstances described in the limitations contained in the two provisos in the immediately preceding sentence will be deemed
to apply absent a final non-appealable judgment of a court of competent jurisdiction to such effect, in which case to the extent any such
limitation is so determined to apply to any Indemnitee as to any previously advanced indemnity payments made by the Company, then such
payments will be promptly repaid by such Indemnitee to the Company without interest. The rights of any Indemnitee to indemnification hereunder
will be in addition to any other rights any such person may have under any other agreement or instrument to which such Indemnitee is or
becomes a party or is or otherwise becomes a beneficiary or under law or regulation.

 

Section 5.2        Disclaimer;
Standard of Care. The Service Provider makes no representations or warranties, express or implied, in respect of the Services. In
no event will the Service Provider or its Related Parties be liable to the Company or any of its affiliates for any act, alleged act,
omission or alleged omission that does not constitute gross negligence or willful misconduct by the Service Provider as determined by
a final, non-appealable determination of a court of competent jurisdiction.

 

ARTICLE VI

 

TERMINATION

 

Section 6.1        Termination.
This Agreement shall terminate upon the earlier of (a) the Termination Date and (b) the mutual agreement of the Parties.

 

    4 

     

    

 

Section 6.2         Effect
of Termination. In the event of a termination of this Agreement, the Company will pay the Service Provider or its designees all unpaid
amounts due pursuant to Article II and Section 5.1 with respect to the periods prior to the termination of this
Agreement. This Section 6.2 and Articles III, IV, V and VII shall survive any termination
of this Agreement.

 

ARTICLE VII

 

MISCELLANEOUS

 

Section 7.1        Independent
Contractor Status. This Agreement shall not be construed as creating any agency, partnership, joint venture, or other similar legal
relationship between or among the Parties; nor will any Party hold itself out as an agent, partner, or joint venture party of another
Party. Each Party shall be, and shall act as, independent contractors. No Party shall have authority to create any obligation for another
Party. Further, the Service Provider shall be responsible for: (1) selecting and hiring its employees legally, including compliance
with all applicable laws in connection therewith; (2) paying its employees’ wages and other benefits that the Service Provider
offers to such employees in accordance with applicable laws; paying or withholding all required payroll taxes and mandated insurance premiums;
(4) providing workers’ compensation coverage for employees as required by law; and (5) fulfilling employer’s obligations
with respect to unemployment compensation. The Service Provider shall indemnify the Company from a claim made by the Service Provider’s
employee or agent against the Company alleging rights or benefits as a Company employee.

 

Section 7.2        Notices.
All notices, statements or other documents which are required or contemplated by this Agreement shall be in writing and delivered (i) personally
or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address
designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as
may be designated in writing by such party, or (iii) by electronic mail, to the electronic mail address most recently provided to
such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted
shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation,
if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days
after mailing if sent by mail.

 

Section 7.3         Entire
Agreement. This Agreement constitute the entire agreement between and among the Parties hereto with respect to the transactions contemplated
hereby, and supersede all written and verbal negotiations, representations, warranties, commitments, and other understandings prior to
the date hereof between the Service Provider and the Company.

 

Section 7.4        Amendment
and Waiver. This Agreement may be amended, and the observance of any clause of this Agreement may be waived, only with the written
consent of all Parties affected thereby. Any waiver by either Party hereto of any provision of this Agreement shall not be construed as
a waiver of any other provision of this Agreement, nor shall such waiver be construed as a waiver of such provision with respect to any
other event or circumstance, whether past, present or future.

 

    5 

     

    

 

Section 7.5         Execution
in Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same agreement. In the event that any signature is delivered by facsimile transmission or any other form
of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such signature page were an original thereof.

 

Section 7.6        Assignment.
The Service Provider hereby acknowledges that the Services to be provided to the Company hereunder are unique and personal. Accordingly,
the Service Provider shall not assign this Agreement or any rights hereunder without the prior written consent of the Company. Any attempted
assignment without such written consent shall be null and void.

 

Section 7.7         Governing
Law; Forum Selection; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with, the laws of the
State of New York, without regard to the conflict of law provisions of such jurisdiction. EACH OF THE PARTIES HERETO IRREVOCABLY SUBMITS
TO THE EXCLUSIVE JURISDICTION OF ANY STATE COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK OR ANY U.S. FEDERAL COURT SITTING IN NEW
YORK COUNTY IN NEW YORK STATE IN RESPECT OF ANY AND ALL SUITS, CLAIMS, DISPUTES, CHALLENGES, ACTIONS OR PROCEEDING ARISING OUT OF OR RELATING
TO THIS AGREEMENT, THE RIGHTS OF ANY PARTY HERETO UNDER THIS AGREEMENT, AND THE PERFORMANCE OF THE OBLIGATIONS IMPOSED BY THIS AGREEMENT
(“CLAIMS”), AND IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION
OF THE AFORESAID COURTS. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO UNDER APPLICABLE
LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH CLAIM BROUGHT IN ANY SUCH COURT AND ANY
CLAIM BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. THE PARTIES WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY DISPUTE
OR OTHER CLAIM IN CONNECTION WITH THIS AGREEMENT.

 

Section 7.8        Severability.
If any provision or provisions of this Agreement shall, for any reason, be deemed unenforceable or in violation of law, such unenforceability
or violation shall not affect the remaining provisions of this Agreement, which shall continue in full force and effect and be binding
upon the Parties hereto. The Parties will use their best efforts to agree upon any changes in this Agreement which may be necessary in
order to adjust its remaining provisions with regard to the omission of any invalid clause in order to make this Agreement workable.

 

Section 7.9        Section Heading.
The headings of the sections, paragraphs, and exhibits herein are for the Parties’ convenient reference only and shall not define
or limit any of the terms or provisions hereof. Exhibits and other documents referred to in this Agreement are an integral part hereof,
unless the context of such reference indicates otherwise.

 

    6 

     

    

 

Section 7.10       Damages.
NOTWITHSTANDING ANYTHING CONTAINED HEREIN TO THE CONTRARY, IN NO EVENT SHALL ANY PARTY HERETO BE LIABLE TO ANOTHER FOR PUNITIVE, INDIRECT, INCIDENTAL
OR CONSEQUENTIAL DAMAGES, INCLUDING LIABILITY FOR LOSS OF USE, LOSS OF PROFITS, LOSS OF PRODUCT OR BUSINESS INTERRUPTION HOWEVER
THE SAME MAY BE CAUSED, INCLUDING FAULT OR NEGLIGENCE OF ANY PARTY.

 

Section 7.11       Construction.
The words “hereof,” “herein,” and “hereunder” and words of similar import when used in this Agreement
refer to this Agreement as a whole and not to any particular provision of this Agreement, and section and subsection references are to
this Agreement unless other-wise specified. The words “include” or “including” when used in this Agreement are
deemed to be followed by the words “but not be limited to” or “but not limited to,” respectively.

 

[The remainder of this page is intentionally
left blank.]

 

    7 

     

    

 

IN WITNESS WHEREOF, the Parties
hereto have caused this Support Services Agreement to be signed as of the date set forth below.

 

	 	BANYAN ACQUISITION CORPORATION
	 	 
	 	By:	 
	 	 	Name: Keith Jaffee
	 	 	Title: Chief Executive Office
	 	 
	 	H&J SPAC Investors LLC
	 	 
	 	By:	 
	 	 	Name: Jerry Hyman
	 	 	Title: Member
	 	 	

 

[Signature Page to Support Services Agreement
]Document

CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.

Distribution Agreement between

ZO® SKIN HEALTH, INC.

&

CUTERA, INC

August 5, 2013

DISTRIBUTION AGREEMENT

THIS DISTRIBUTION AGREEMENT is made on August 5, 2013, and shall become effective on October l , 2013 (the "Effective Date") by and between ZO SKIN HEALTH, INC., a company established and existing under the laws of the State of California, having its principal place of business at 1 Technology Drive, Suite B-123, Irvine, CA 92618, USA, ("ZO SKIN HEALTH") and CUTERA, INC., a corporation organized and validly existing under the laws of Delaware, having  its  principal  place of  business  at  3240 Bayshore  Blvd.,  Brisbane, CA   94005,  USA (" Distributor''). ZO SKIN HEALTH and the Distributor are sometimes referred to herein collectively as the "Parties'' and individually as "Party."

RECITALS

WHEREAS, ZO SKIN HEALTH develops and markets a line of products known as " ZO Medical," as described in Section 1.8 below and Exhibit A attached hereto and incorporated herein by this reference, but contracts to have the Products manufactured for it by unaffiliated manufacturing businesses;

WHEREAS, ZO SKIN HEALTH desires to have Distributor distribute the Products and Related Products (defined in Section 3 hereof) in the Territory identified below; and

WHEREAS, ZO SKIN BEALTH and Distributor deem it to be in their mutual best interests to enter into an agreement whereby Distributor shall be appointed as an exclusive distributor of the Products and Related Products in the Territory and under the terms and conditions set for below.

NOW THEREFORE, in consideration of the recitals set forth above and the terms, conditions and mutual covenants set forth below, the Parties agree as follows:

1.    DEFINITIONS

For purposes of this Agreement, the following words shall have the following meanings:

1.1    “Affiliate” means, with respect to any specific entity, any other entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such specified entity, or has a contractual relationship with such specified entity.

1.2    “Agreement” means this Distribution Agreement and all exhibits, schedules and annexes which are attached to this Agreement from time to time and form a part hereof.

1.3    “Channels of Distribution” means distribution through physicians' offices and medical spas where a physician  is on-site and responsible for administering of the Products; but, it excludes all other channels of distribution .including resort spas, mass merchants, warehouse clubs, traditional food and drug stores, web sites and e-tailers (e.g., drugstore.com, etc.). The Products and Related Products sold to Distributor under this Agreement may be resold over the internet through Distributor’s website for the sole purpose of fulfilling orders of existing Customers. No other internet sales are authorized by this Agreement. Distributor agrees to establish and maintain appropriate measures to ensure that the Products and Related Products are
			
	Distribution Agreement ZO Medical—Int’l Form v. 4.0 - Cutera final-2

			
	2

only distributed within the Territory and sold pursuant to the terms of this Agreement.

1.4    “Confidential Information” is defined in Section 13.l hereof.

1.5    “Customer” means any entity or business described in Section 1.3 who used or  uses the Products  and  Related Products in servicing its  clients,  who purchases the  Products and Related Products from the Distributor or an approved sub-distributor in the Territory for resale or for use solely within the Channels of Distribution in the Territory.

1.6    “Distributor Purchase Prices” means the prices payable by Distributor to ZO SKIN HEALTH as consideration for the purchase by Distributor of the Products and Related Products, as set forth in Exhibit A, as may be unilaterally amended from time to time by ZO SKIN HEALTH after 60days' advance written notice to Distributor.

1.7    “ZO SKIN HEALTH Marks” means the trademarks, trade names and service marks, domain names, and logos of ZO SKIN HEALTH and other commercial symbols identifying ZO SKIN HEALTH or the Products and Related Products and/or other products and services of ZO SKIN HEALTH, including those set forth in Exhibit C, and those developed  in the future, as the same may be modified, deleted or supplemented at any time upon written notice from ZO SKIN HEALTH.

1.8    “Products” means the "ZO Medical" line of skin care products produced by or for ZO SKIN HEALTH as described in Exhibit A, which exhibit may be unilaterally amended by ZO SKIN HEALTH after 60 days' advance written notice to Distributor, thereby adding and deleting Products available for distribution from time to time.

1.9     “Proprietary Information” is defined in Section 13.1.

1.10“SKU” or a "Stock Keeping Unit" is an identifier to permit the tracking of Products or Related Products by unit, type of Product or Related Product or one or more particular Product or Related Product.

1.11 “Territory” means the country(ies) set forth in Exhibit A, including, without limitation, their territories and possessions and any other geographic area agreed upon in writing by the Parties for the exercise of Distributor's rights and obligations in this Agreement.

1.12 “Trade Secrets” is defined in Section 13.1.
2.    APPOINTMENT

2.1    Grant of Rights. ZO SKIN HEALTH hereby grants to Distributor, and Distributor hereby accepts, upon the terms  and conditions  set  forth  in  this  Agreement,  the  exclusive right to promote, market, sell, distribute through itself and approved sub-distributors, if any, the Products and Related Products to Customers located  within the Territory for sale or use within the Territory and only within the Channels of Distribution.

2.2    Technical and Sales Literature License. During the term of this Agreement, and subject to its terms and conditions, ZO SKIN HEALTH grants to Distributor a nonexclusive,
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

nontransferable, royalty free license, to use those ZO SKIN HEALTH Marks which are related to the Products and Related Products and the ZO SKIN HEALTH sales and technical literature and materials to exclusively promote, market, sell and distribute the Products and Related Products in the Territory.
2.3    Sales Outside the Territory, Channels of Distribution; Internet Sales. Unless specifically authorized in writing by ZO SKIN HEALTH, Distributor shall not: (a) through itself, or any sub-distributor or Customer, distribute, sell or otherwise provide the Products or Related Products outside the Territory or outside the Channels of Distribution; (b) advertise, promote or solicit Customers for the Products or Related Products outside the Territory or outside the Channels of Distribution; (c) sell or distribute the Products or Related Products to any sub-distributor or Customer who it knows sells the Products or Related Products outside the Territory or outside the Channels of Distribution; (d) promote or sell the Products or Related Products to the general public using the Internet; (e) sell or distribute the Products or Related Products to any sub-distributor or Customer who it knows sel1s the Products or Related Products on its website; and (f) sell or distribute the Products or Related Products to any sub distributor or Customer who it knows promotes or sells the Products or Related Products to the general public using the Internet. Distributor and ZO SKIN HEALTH shall monitor Distributor's and, if applicable, its sub-distributors' distribution and sale of the Products and Related Products to insure that the Products and Related Products are not, directly or indirectly, being redistributed or resold outside the Territory or outside the Channels of Distribution. Distributor shall be responsible for any violation of this section by it or any person or entity who receives the Products or Related Products, directly or indirectly, from Distributor. Distributor shall immediately  terminate any sub-distributor agreement or Customer agreement and immediately stop selling to a sub-distributor or Customer if it learns that the sub-distributor or Customer, directly or indirectly, distributed the Products or Related Products outside the Territory or outside the Channels of Distribution; by doing so, Distributor shall not be in breach of this Agreement as a result of such activity by the sub-distributor or Customer. Except as otherwise specifically provided herein, any violation of this Section 2.3 shall be deemed an immediate, incurable breach of this Agreement which constitutes grounds for termination of this Agreement by ZO SKIN HEALTH, in addition to any other remedies available to ZO SKIN HEALTH under this Agreement, at law or in equity. Notwithstanding the immediately preceding sentence,  if there is  not a  pattern of violations of this Section 2.3, as determined by ZO SKIN HEALTH, in its discretion, then Distributor shall have a period of 30 days to cure the breach after receipt of  written  notice of such violation from ZO SKIN HEALTH.   Waiver by ZO SK.IN HEALTH of any violation of this section by Distributor or Distributor's sub distributors or their Customers shall not constitute a waiver of any other violations under this section. For purposes of this Section 2.3, the term “indirectly” refers to actions by: (a) a subdistributor, (b) a Customer, (c) any Affiliate of Distributor, or a sub-distributor or Customer, or
(d) any person or business specifica11y directed by Distributor, or a sub-distributor or Customer, or an Affiliate of any of them, to circumvent the provisions set forth above.
2.4    Reserved Rights. Except as otherwise set forth in this Agreement, no express or implied right is granted to Distributor regarding the Products or Related Products, the ZO SKIN HEALTH technical and sales literature or the ZO SKIN HEALTH Marks. Distributor acknowledges that all copyright, patent, trade secret and other intellectual property rights in and to the Products and that ZO SKIN HEALTH may have in the Related Products, ZO
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

SKIN HEALTH technical and sales literature and the ZO SKIN HEALTH  Marks are the sole property of ZO SKIN HEALTH. ZO SKIN HEALTH reserves all rights not expressly granted herein.

2.5    Sub-Distributors. As of the Effective Date, the Parties do not intend for Distributor to have the right to use sub-distributors. Consistent therewith, Distributor shall not, without the prior written consent of ZO SKIN HEALTH, which consent may be withheld by ZO SKIN HEALTH in its sole and absolute discretion, appoint .any third party as a sub-distributor of Distributor (“sub distributor”), which includes without limitation Distributor selling or consigning Products or Related Products to any person or entity that is not a Customer, to promote, market, distribute and/or sell the Products and Related Products within the Territory. Distributor shall submit to ZO SKIN HEALTH for written approval prior to Distributor engaging a sub-distributor to promote, market distribute and/or sell the Products or Related Products, Distributor’s written agreement with the sub-distributor, which shall contain at least the contractual obligations and rights set forth in Exhibit E attached hereto. The rights granted to a sub-distributor shall not, in any event, be greater than the rights of Distributor under the terms of this Agreement; and, Distributor shall remain primarily responsible for any and all actions taken by sub-distributor.

2.6    Pricing. The following provisions of this Section 2.6 shall be effective to the extent that they do not violate the laws of Japan. If, at any time, it is determined that the following provisions violate Japanese law, then to the extent prohibited by law, they shall not be followed by the Parties. ZO SKIN HEALTH will provide Distributor from time to time in writing with a suggested price at which the Products and Related Products should be sold to Customers. In the event Distributor or its sub-distributor shall sell Products or Related Products to its Customers at a
price below the suggested price to Customers (such factual circumstances are hereafter referred to
as the “Pricing Default”), ZO SKIN HEALTH may on thirty (30) days’ advance written notice to the  Distributor  or  sub-distributor terminate  the  Distribution  Agreement  or  sub-distributor
. agreement. Distributor hereby appoints  ZO SKIN HEALTH as  its attorney in fact, which
appointment is coupled with an interest, for the sole purpose of terminating a sub-distributor pursuant to the foregoing sentence. If a Pricing Default arises from the conduct of a sub distributor, rather than Distributor, then Distributor shall immediately stop selling the Products
and Related Products to that entity upon learning of that conduct by written notice from ZO SKIN HEALTH or otherwise; by doing so, Distributor shall not be in breach of this Agreement as a result of such activity by the sub-distributor. Failure of ZO SKIN HEALTH to terminate the
Distributor or a sub distributor within ninety (90) days from a Pricing Default shall constitute a waiver of its termination rights for that particular occurrence, but not for any other Pricing Defaults.

3.    ADDITIONAL PRODUCTS

3.1    Related Products.  ZO SKIN HEALTH may from time to time offer products for sale related to the “ZO Medical” line of products which are not listed in Exhibit A (“Related Products”). Such Related Products, new or not, may be unilaterally added to Exhibit A by ZO SKIN HEALTH at any time and shall  thereafter become subject to this Agreement.   If ZO SKIN HEALTH, in its sole discretion, chooses to distribute such Related Products in the Territory during the term of this Agreement, ZO SKIN HEALTH shall offer Distributor the exclusive right to promote, market, sell and distribute such Related Products in the Territory
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

within the  Channels of Distribution,  subject to the terms of  this Agreement, which offer shall be open for acceptance for a period no longer than thirty (30) days. In the event Distributor chooses not to accept ZO SKIN HEALTH’s offer to include any such Related Products as a part of  its Minimum. Product  Purchases  under  Section  4.l(a) hereof , ZO  SKIN  HEALTH may enter into distributor agreements with other distributors in the Territory for the distribution of such Related Products to Customers without further obligation to Distributor.

3.2    Excluded Products. Not included in the products which are subject to this Agreement are products sold under the label “ZO Skin Health.” Absent a separate written agreement executed by both Distributor  and  ZO SKIN HEALTH  for  that label, Distributor has no  right to  distribute such products.   In  the event Distributor  and ZO SKIN HEALTH enter into an agreement for distribution of the “ZO Skin Health” line of  products, a  breach of that agreement shall be deemed  a  breach of  this  Agreement; if  that agreement is terminated as a result of the breach, this Agreement shall also be terminated as a result of such breach.

3.3    Cooperation with Distributor of ZO Skin Health Products. If Distributor is not also selling the “ZO Skin Health” line of products, then Distributor shall reasonably cooperate with the entity engaged by ZO SKIN HEALTH to sell the “ZO Skin Health” line of products in the Territory so as to enhance the mutual success of that entity and Distributor in their respective spheres.

4.    GENERAL OBLIGATIONS OF DISTRIBUTOR

4.1    Minimum Purchase Requirement.

(a)    Minimum Product Purchases. Subject to Section 3 above, Distributor must purchase all Products and Related Products offered from time to time by ZO SKIN HEALTH to the Distributor.

(b)    Minimum Purchase Requirement. During the term of this Agreement, Distributor shall make at least the minimum purchases  of  Products  and  Related Products from ZO SKIN HEALTH as required by Exhibit A. Purchases counted toward the Minimum Purchase Requirement for any period provided for herein shall be based upon ZO SKIN HEALTH’s net invoice prices for the Products and Related Products which are paid by Distributor prior to the expiration of the applicable calendar year.

(c)    Termination of  Distributor Rights.  In the  event that the Distributor fails to achieve the Minimum Purchase Requirement set forth above in any calendar year, then Distributor shall arrange to meet with ZO SKIN HEALTH during the first quarter following the end of the year in question to discuss developing an improvement plan and/or changing the Minimum Purchase Requirement for future periods. Both ZO SKIN HEALTH and Distributor have the obligation to negotiate in good faith; however, ZO SKIN HEALTH shall not be required to accept a lower Minimum Purchase Requirement. If they fail to develop an improvement plan or agree to a revised Minimum Purchase Requirement for future periods, then the failure shall constitute grounds, at ZO SKIN HEALTH's sole discretion, to terminate this Agreement, which it may do at any time during the second quarter following the end of
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

the year in question. Waiver by ZO SKIN HEALTH  of  any failure  to meet the Minimum Purchase Requirement shall not constitute a waiver  of  any rights that ZO SKIN HEALTH may have with respect to any other failure to meet the Minimum Purchase Requirement.

(d)    Notwithstanding subsections  (a) through (c) above, if  Distributor also has a contract with ZO SKIN HEALTH for distribution of its “ZO Skin Health” line of products, then Distributor may fail to reach the Minimum Purchase Requirement under this Agreement by ten xxxxxxxxx) or less without violating this Agreement if the cumulative total purchases under both this Agreement and the agreement for the “ZO
Skin Health” line of products equals or exceeds the sum of the Minimum Purchase Requirements under both agreements.

4.2    Promotion and Marketing.  Distributor shall use commercially reasonable efforts to further the promotion, marketing, sale and distribution of the Products and Related Products  in  the Territory. including but not limited to, building brand awareness and value.  During the term of this Agreement, the Distributor shall expend on a calendar year basis, for the advertising of the Products and Related Products in the Territory through media advertisements,  public   relations, promotions, merchandising, tradeshows, workshops, and displays (in each case as previously approved  by ZO  SKIN HEALTH in writing), not less than an amount equal to xxx of net sales of the Product and Related Products made during such calendar  year, at  the           discretion of the Distributor. Notwithstanding anything herein to the contrary, no payroll costs of any kind (including, without limitation, salaries and/or commissions payable to beauty consultants) shall be applied toward the minimum advertising expenditures required pursuant to this section. The cost of general media (including agency fees, production fees and cooperative advertising); gift-with-purchase; promotion displays and their installation costs; public re1ations activities; samples and testers; and Collateral Materials may be applied toward the minimum advertising expenditure required above. Distributor shall upon written request provide ZO SKJN HEALTH with documentation of all such expenditures as well as photographs, ad copy, and all other relevant documents relating to its public relations efforts. ZO SKIN HEALTH may, in its reasonable discretion,  prepare  promotional  programs  for  the Products  and  Related  Products in  the Territory and   Distributor  agrees  to  cooperate  with ZO  SKIN  HEALTH  in  sales  or  promotional programs prepared by ZO SKIN HEALTH.  Distributor shall not make, nor permit  its sub-distributors to make, any materially misleading or untrue statements concerning the Products or Related Products. In addition:

(a)    Distributor shall maintain an office and well-trained staff to promote the sale of the Products and Related Products, and to solicit orders for them.

(b)    Distributor shall provide full and accurate advice and assistance to Customers when soliciting orders for Products and Related Products.

(c)    Distributor shall handle promptly, efficiently, courteously and properly all inquiries, quotations, correspondence, orders and complaints in connection with the Products and Related Products.

(d)    Distributor shall promptly inform ZO SKIN HEALTH of any complaints
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

that it receives that are of either a material or a recurring nature.

(e)    Distributor shall use its best commercial effort to ensure that the location and display of the Products and Related Products in each location in which the Products and Related Products are sold in the Territory will be at least as favorable as the location of any similar or competitive products.

(f)    If Distributor shall be affiliated with any customer of the Products and Related Products, Distributor shall not favor such Affiliate over any other customer.

(g)    Distributor shall make  no representation, guarantee or  warranty,  either
express  or  implied, with  respect to any Product or Related Product, beyond those contained in ZO SKIN HEALTH approved package labels and products instructions, without the express written consent of ZO SKIN HEALTH or as otherwise required by the laws of the jurisdiction in which the Products and Related Products are offered for sale in the Territory. Distributor shall not have the right, power or authority to make any representation, guarantee or warranty on behalf of ZO SKIN HEALTH. Distributor shall not make or cause to be made or authorize any modifications or additions to the Products or Related Products without the express prior written consent of ZO SKIN HEALTH.

(h)    Distributor shall at all times keep and maintain at its office set forth above accurate accounts and records of all transactions pertaining to the Products and Related Products and to this Agreement. All such accounts and records shall be retained by Distributor during the term of this Agreement and for a period of three (3) years after the date of  any termination of this Agreement and, upon mutual consent of the Parties, shall be  subject  to examination and audit by ZO SKIN HEALTH or its authorized representative,  during  normal  business hours.  Distributor  shall at all times promptly make available to ZO SKIN HEALTH such of its records as are necessary for ZO SKIN HEALTH to fulfill any recall or other obligation it deems necessary under any applicable law, rule or regulation and such  obligations shall survive  and  continue after termination of this Agreement.

4.3    Competing Products.    During the term of this Agreement, Distributor shall  not sell,  distribute,  market,  advertise  or solicit  purchase  orders for any  product  that  is competitively positioned  in  the Territory with  ZO  SKIN  HEALTH's  products,  including  without  limitation, the Products and Related Products.  However, notwithstanding the  immediately preceding sentence, the Distributor shall have the right to distribute the inventory of competitively positioned products that it purchased prior to the Effective Date of this Agreement until  the end of business on March 31, 2014; except that, those products listed on Exhibit F attached  hereto  and incorporated herein by this reference may be purchased and sold by Distributor until the end of business on September 30, 2015. The term "competitively positioned" refers to medical and cosmeceutical skin care products marketed and sold through the Channels of Distribution . Except as provided above, Distributor shall promptly terminate any sub-distributor who without the written consent of the Parties sells, distributes, markets, advertises or solicits purchase orders for any product that is competitively positioned with ZO SKIN HEALTH's products in the Territory.  Distributor shall advise ZO SKIN HEALTH in writing of (i) any known or suspected duplication of the Products or Related Products, (ii) competitors in the
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

Territory competing with the Products and Related Products, and (iii) any change in regulations and/or practices within the Territory affecting the use of the Products and Related Products. Distributor and its sub-distributors, if applicable, shall at all times make ZO SKIN HEALTH’s Products and Related Products the primary focus of their marketing and sales efforts.

4.4    Business Plan and Reporting. By the 1st business day of November, 2013, Distributor shall create a business plan (“Business Plan'”) for the marketing, distribution and sale of  Products  and  Related Products in the Territory and by October lst of each year prepare the same for the following calendar year. The Business Plan shall include a description of the Distributor's   sales   organization  (including   that  of  any  sub-distributors),  a  competitive  market analysis, methods of distribution, a marketing plan, projected quarterly sales by Products and Related Products, and such other information ZO SKIN HEALTH may reasonably request from  time to time.  Following  the end  of each calendar year during the term of this Agreement, but no later than March 15th  of the following  year, Distributor shall send to ZO SKIN HEALTH a report containing the number of accounts, the nature of the accounts, a market review, etc., in form and substance mutually agreed to by ZO SKIN HEALTH and Distributer.

4.5    Governmental Requirements. Subject to the terms of this Agreement, Distributor shall,  and shall require its sub-distributors to (i) comply with all applicable laws and regulations of the United States and the Territory, including but not limited to, export laws and restrictions and regulations of the United States Department of Commerce or other United States or foreign agency or authority, and shall not export, or participate in any transaction which may involve the export or re-export of any Products or Related Products in violation of any such restrictions, laws or regulations; (ii) assist ZO SKIN HEALTH in obtaining any required  registrations, licenses  and permits  for  the  Products  and  Related  Products  and the marketing, sale and distribution of the Products and Related Products in the Territory by supplying such documentation or information as may be reasonably requested by ZO SKIN HEALTH; and (jii) obtain and maintain during the term of this Agreement all governmental approvals and licenses necessary to import the Products and Related Products into the Territory. If any governmental registration, license or approval for the marketing, sale and distribution of the Products and Related Products is required, Distributor shall obtain ZO SKIN HEALTH’s written approval prior to commencing any registration or approval process. Unless otherwise  required  by applicable law, all registrations, licenses  and  approvals for the Products and Related Products and the distribution of the Products and Related Products in the Territory shall be in the name of and shall be solely owned by ZO SKIN HEALTH.  ZO SKIN HEALTH
will reimburse Distributor for any pre-approved and reasonable fees for assistance in
obtaining such registrations, licenses and approvals that are in ZO SKIN HEALTH's name or that are transferred to ZO SKIN HEALTH on termination of this Agreement. Distributor shall provide ZO SKIN HEALTH with a copy of all registrations, licenses and approvals obtained or received for the Products and Related Products and for the distribution of the Products and Related  Products  in the Territory within five (5) business days of Distributor's receipt of each such  registration, license and approval.  Should Distributor, either prior to this Agreement or at any time after execution of this Agreement, obtain a registration, license or approval for the Products and Related Products or for the distribution of the Products and Related Products in the Territory, Distributor agrees to immediately take the appropriate action to transfer such registration, license or approval to ZO SKIN HEALTH as required above and as is consistent
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

with  the  spirit  and  intent  of this Section 4.5. In furtherance of, but without  limiting  the foregoing, Distributor represents that it has read, understood and will comply and cause its sub distributors to comply with the anti-bribery provisions of the U.S. Foreign Corrupt Practices Act. Distributor covenants and agrees that it shall promptly notify ZO SKIN HEALTH of any disciplinary  action  or change  in  status with regard to any license,  permit or  authorization required  by law.  For its pact, ZO SKIN HEALTH recognizes the need for the Distributor to comply with all local legal requirements and that from time to time such legislation may prevent the Distributor from fully complying with one or other terms of this Agreement. In such cases, providing sufficient evidence is provided, ZO SKIN HEALTH will not deem a failure to comply with that term or condition a breach of this Agreement.

4.6    Distributor Expenses. Except as provided in Section 4.5, Distributor assumes full
responsibility for all its own costs and expenses incurred in carrying out its obligations under this Agreement, including but not limited to all rents, salaries, commissions, advertising, translations of documents and materials, demonstration, travel and accommodation for the employees, agents, representatives or other personnel of Distributor.

4.7    Marketing Materials. All marketing materials created by or for Distributor or for any sub-distributor relating to the Products and Related Products shall be approved in writing within 7 days of submission by ZO SKIN HEALTH prior to use by Distributor or any sub distributor.  Such  marketing  materials shall contain copyright, trademark  and  accreditation notices as prepared by ZO SKIN HEALTH. An approved  sub-distributor shall not be permitted to  create  any marketing materials with respect to Products or Related Products.   Further, the name “ Obagi” may only be used to sell, market, or advertise products or services if “Obagi” is
part of  the phrase “ by  Zein  Obagi,  M.D.”  and  so  long as  the phrase “by Zein Obagii, M.D.”
appears in a font size not materially different than the proportional relationship to the font size of “ZO ®  MEDICAL” that is shown in Exhibit C.    Any violation of the requirements set forth in the immediately preceding sentence shall be considered a material breach of this Agreement.

4.8    Quarterly Forecast. Distributor shall provide ZO SKIN HEALTH with reports of its activities, competitor activities, and other information regarding the Products and Related Products and the markets for them in the Territory in such detail and with such frequency as ZO SKIN HEALTH shall reasonably require from time to time. In order to help ZO SKIN HEALTH provide inventory on a timely and consistent basis to Distributor, Distributor agrees to provide to ZO SKIN HEALTH on a quarterly basis a twelve (12) month rolling forecast of Distributor’s projected purchase orders (including that of sub-distributors) on the form attached hereto as Exhibit B.  Distributor's provision of the above-mentioned forecast shall not be interpreted as a commitment from Distributor to buy any Products or Related Products in excess of Distributor's Minimum Purchase Requirement, unless otherwise agreed to in writing by the Parties.

4.9    Development of Faculty. ZO SKIN HEALTH anticipates that Dr. Zein Obagi will, from time to time, conduct seminars and make other public appearances to promote ZO SKJN HEALTH products within the Territory, for the mutual benefit of ZO SKIN HEALTH and Distributor. Dr. Obagi’s standard personal appearance fee will be borne by Distributor, and a separate personal appearance contract will be executed by and between Dr. Obagi and Distributor
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2

			
	3

prior to any such appearance. ZO SKIN HEALTH and Dr. Obagi intend to associate with other qualified physicians to form a faculty of professionals who are trained and qualified to conduct seminars and other public appearances either 'in conjunction with Dr. Obagi or on his behalf. Distributor  agrees  to use its best efforts to help locate suitable physicians who are willing, able, and qualified to become part of that faculty, and to make introductions or otherwise facilitate a relationship between those physicians and ZO SKIN HEALTH.

4.10    Free Goods.   ZO SKIN HEALTH will provide xxx of Net Sales as Free Goods and Related Products and collaterals in the first year of this Agreement; for each year thereafter, the above percentage shall be xx.

5. GENERAL OBLIGATIONS OF ZO SKIN HEALTH

5.1    General.  ZO SKIN HEALTH shall use commercially reasonable efforts to maintain and  enhance  the  reputation,  usefulness,  and  acceptance of its  Products  and  Related Products and to assist Distributor in all reasonable ways to promote the sale of the Products and Related Products in the Territory.

5.2    Distributor Training. ZO SKIN HEALTH shall provide initial training on the Products and Related Products and subsequent training upon the release of new Products or new Related Products that are subject to this Agreement. The date, duration, content and location of the initial training and training relating to any new Products or Related Products shall be  as  ZO SKIN HEALTH determines from time to time to be reasonable and appropriate after communicating with and considering the interests of Distributor. Notwithstanding the foregoing, Distributor and ZO SKIN HEALTH shall each bear their own costs of travel and living  expenses  for their  own  personnel to participate in training, whether for initial or subsequent training for the release of new Products or Related Products. If training is provided at Distributor's location, Distributor shall provide reasonable training facilities without expense to ZO SKIN HEALTH.   Distributor shall be solely responsible for any other training of its sales staff.
5.3    Marketing Support. ZO SKIN HEALTH shall provide Distributor with an electronic and one hard copy of ZO SKIN HEALTH’s marketing materials in English. Distributor  shall  provide language translations of such materials that Distributor plans to use within the Territory to ZO SKIN HEALTH at Distributor’s sole expense. Distributor shall not change the literal meaning of the ZO SKIN HEALTH technical information or sales literature or materials provided to it without Distributor providing ZO SKIN HEALTH with an accurate interpretation of any changes and securing ZO SKIN HEALTH’s express written permission for the changes. Such translated material shall be in conformity with the requirements of Section 4.7 hereof and shall be produced at Distributor’s sole expense.

6.    PURCHASE OF PRODUCTS, RELATED PRODUCTS AND SERVICES

6.1    Purchase Orders and Delivery. Distributor shall order Products and Related Products only from ZO SKIN HEALTH. All purchases of Products and Related Products by Distributor from ZO SKIN HEALTH hereunder shall be purchased and paid for at the Distributor Purchase Prices. Products and Related Products ordered by Distributor from ZO
			
	11

			
	Distribution Agreement ZO Medical· Int’l Form v. 4.0 · Cutera fina-l2

SKIN  HEALTH  will  be  delivered  by  ZO SKIN HEALTH directly to the Distributor’s designated freight forwarding agent. ZO SKIN HEALTH shall use commercially reasonable efforts to deliver ordered Products and Related Products  within thirty (30) days of  the date of  receipt of a purchase order from Distributor. All Products and Related Products with a stated  shelf  life of more than two years shall have a minimum of 24 months of remaining shelf life at the time of shipment from ZO SKIN HEALTH to Distributor, and all Products and  Related  Products  with  a stated shelf life of two years shall have a minimum of 18 months  of remaining shelf life at the time of shipment from ZO SKIN HEALTH to Distributor.

6.2    Modification of Orders. All order(s) of Distributor are non-cancelable, non refundable and non-exchangeable, except as otherwise agreed to in writing by the Parties. All order(s)  placed  with ZO SKIN HEALTH  by Distributor  for  Products and Related Products shall be made through the submission of a purchase order in the form required by ZO SKIN HEALTH from time to time.

6.3    Delivery Terms.  All deliveries of the Products and Related Products shall be FOB ZO  SKIN  HEALTH’s  manufacturing  or  warehouse  facility.  ZO  SKIN  HEALTH  shall  consign  each  shipment  to the freight forwarding agent and customs broker specified by Distributor in the purchase order.

6.4    Title. Title to each of the Products and Related Products shall transfer upon consignment and delivery by ZO SKIN HEALTH at ZO SKIN HEALTH’s facility to the freight forwarding agent specified in Distributor’s purchase order. ZO SKIN HEALTH may, but is not required  to,  purchase insurance for loss, damage or theft of Products and/or Related Products while they are in transit and it may charge Distributor for any such insurance purchased.

6.5    Acceptance of Products and Related Products. ln the event of any shortage, damage or discrepancy in or to a shipment of Products or Related Products, Distributor shall promptly report the same to ZO SKIN HEALTH and furnish such written evidence or other documentation as ZO SKIN HEALTH may deem appropriate. ZO SKIN HEALTII shall not be liable  for  any  such  shortage, damage or discrepancy unless ZO SKIN  HEALTH  has received  sufficient  notice  and evidence  thereof  from Distributor  within thirty (30) days from ZO SKIN HEALTH’s delivery of  the Products or Related Products to Distributor’s freight  forwarding  agent. If such evidence  demonstrates to  ZO SKIN HEALTH's satisfaction that ZO SKIN HEALTH is responsible for such shortage, damage or discrepancy, ZO SKIN HEALTH  shall  at  its  sole  obligation promptly deliver additional or substitute Products or Related Products to Distributor therefor.

6.6    Return of  Defective Products or Related Products. ZO SKIN HEALTH shall use reasonable commercial efforts to supply Distributor with Products and Related Products manufactured in accordance with applicable good manufacturing practices. In the event Products and Related Products which are delivered to Distributor are not commercially acceptable in the ordinary course of business in the Territory and the Products or Related Products were delivered by ZO SKIN HEALTH to Distributor within one hundred twenty
(120)  days  from  ZO SKIN HEALTH’s receipt of written  notice  of  defect  from  Distributor, ZO SKIN  HEALTH  shall  reasonably replace  the Products  or Related Products (the
			
	12

			
	Distribution Agreement ZO Medical • Int’l Form v 4.0-Cutera final-2

"Defective Product") or credit Distributor for the purchase price reflected on the invoice for the Defective Product, provided Distributor: (a) has obtained ZO SKIN HEALTH’s prior
written  consent  to return  or  destroy the  Defective Product,  that will  not  be  withheld
unreasonably; and (b) Distributor returns or destroys with ZO SKIN HEALTH’s prior approval the Defective Product within ninety (90) days from the date of receipt of the written consent to return  or destroy from ZO SKIN HEALTH to  Distributor  accompanied  by a completed  Product  Complaint  Form, in the form attached hereto as Exhibit D. All costs associated with the return or destruction of the Defective Product will be borne by ZO SKIN HEALTH.  The  provisions  of this Section 6.6 shall constitute  Distributor's  sole  and exclusive remedy with respect to Defective Products. Distributor shall provide all reasonably requested assistance with respect to any Products or Related Products recalls initiated by ZO SKIN HEALTH or by any governmental agency or authority.

6.7    Price Changes Notification. Distributor Purchase Prices offered to Distributor are and shall remain based on standard distributor discounts from current US pricing. ZO SKIN HEALTH shall give written notice to Distributor of any amendment to the Distributor Purchase Prices of Products or Related Products at least sixty (60) days in advance of the change.

6.8    Price Increase Protection. Any orders from Distributor for Products or Related Products which are received by ZO SKIN HEALTH prior to the effective date of a price increase shall be invoiced at the previous price.  Price protection will be extended to Distributor by ZO SKIN HEALTH for the purpose of satisfying legally binding Customer purchase  agreements  and  quotations for Products  or  Related Products with  Distributor which  are  in force on the effective date of the price increase. In order to obtain price protection, Distributor must provide ZO SKIN HEALTH with satisfactory documentation of such purchase agreement or binding quotation, prior to the effective date of the price increase.
6.9    Price Decrease Protection. In the event ZO SKIN HEALTH decreases the price of any  Products   or Related  Products, Distributor may apply for a  credit for  Products  or Related  Products  purchased  by  Distributor  within  sixty  (60)  days  of  the  announced price  decrease  (the “Qualifying  Product”).   The credit  shall  be  given  in  product  and  shall be equal to the difference between the price paid by Distributor for the Qualifying Product, (less  any  prior credits granted by ZO SKIN HEALTH) and the announced decreased price for the Products or Related Products. Issuance of the price protection credit by ZO SKIN HEALTH is contingent upon Distributor’s submission to ZO SKIN HEALTH, not later than thirty (30) days after the effective date of such price decrease, of an accurate report of the Qualifying Product.  Upon verification  of the inventory  report by ZO SKIN HEALTH, a credit in product will be given to Distributor no later than sixty (60) days after receipt by ZO SKJN HEALTH of such report.

6.10    Product Changes. ZO SKIN HEALTH may at any time upon sixty (60) days’ advance written notice to Distributor without liability to Distributor:

(a)    Alter the specifications for any Products or Related Products;

(b)    Discontinue the development of any new Products, whether or not such new Products have been announced publicly;
			
	Distribution Agreement ZO Medical - Int'! Form v. 4.0 • Cutera, final-2    l 3

(c)    Discontinue the sale of any Products; and

(d)    Commence the development and distribution of new Products and Related Products which may make any current Products or Related Products obsolete.

7.    PRICES AND PAYMENT TERMS

7.1     Products and Related Products Prices. Subject to Sections 6.7 through 6.9 above, ZO SKIN HEALTH may, in its sole discretion, change the Distributor Purchase Prices for Products and  Related Products  listed  in  Exhibit A at any time. Subject to the provisions of Section 2.6, ZO SKIN HEALTH may, in its sole discretion, adjust the suggested price at which the Products and Related Products should be sold to Customers and the suggested retail price at which the Products and Related Products are to be sold to the public (i.e., end-user) from time to time. All Distributor Purchase Prices shall be measured in U.S. dollars.

7.2    Payment Terms.  The first order shall be prepaid. Thereafter, as long as Distributor is not in breach of this Agreement,  Distributor’s invoices shall be due net thirty (30) days. Distributor shall pay ZO SKIN HEALTH by international bank wire transfer to an account specified by ZO SKIN HEALTH in ZO SKIN HEALTH’s invoice to Distributor, or by a confirmed letter of credit or an approved credit card. All payments shall be made in U.S. dollars.

7.3    Delinquent Accounts.  All amounts due and owing to ZO SKIN HEALTH hereunder, but  not  paid  by Distributor in accordance  with  the permitted net  payment terms, shall  become  immediately due and owing (the “Delinquent Accounts”).  The  Delinquent Accounts shall, for  the  first thirty (30) days of delinquency, bear interest in U.S. dollars at the rate of the lesser of: (i) four percent (4%) per annum above the then applicable prime interest
rate  announced  by  the  Wall  Street Journal for  90-day  U.S.  dollar  loans  to  prime commercial  customers  in  the  United States; or (ii) the maximum lawful interest rate permitted under California law.  Any  Delinquent  Accounts not  paid  within the first thirty
(30) days of  becoming delinquent shall bear interest at the lesser of (x) eighteen percent (18%) per  annum or (y) the highest rate permitted by California law, until paid.  Such  interest shall at  all   times accrue monthly  on  the balance of the Delinquent Accounts. Timely payment is a material term of this Agreement. Failure by Distributor to pay an invoice within 60 days of invoicing shall excuse ZO SKIN HEALTH from its obligation to ship any further Product or Related Product and entitle it to terminate Distributor’s rights under this Agreement, without an opportunity to cure. This right to terminate shall continue for 90 days after the invoice is paid and is not waived by acceptance of payment.

7.4    Taxes. Distributor shall be responsible for all taxes payable in the Territory. Distributor, by way of illustration and not by way of limitation shall be responsible for all excise, sales,  use, GST  and value added  taxes  relating  to  Products and Related Products sold in the Territory, including any goods and services taxes payable in the Territory.

8.    TERMS AND TERMINATION

8.1    Term. This Agreement shall commence on the Effective Date and shall continue in effect for a period of five (5) years, unless otherwise terminated pursuant to the provisions
			
	14

			
	Distribution Agreement ZO Medical • ln t’l Form v. 4,0 - Cu1era final-2

of this Agreement. Further, if Distributor has not, at any time, breached any material term of this Agreement, then at the election of Distributor, which shall be communicated to ZO SKIN HEALTH in writing at least 180 days prior to the end of the then-current term, the term of this Agreement shall continue for a subsequent 2-year period.

(a)    Distributor' s  right to continue this Agreement for subsequent 2-year periods shall continue as long as Distributor has not breached a material term of this Agreement  and  Distributor provides timely notice of its election to ZO SKIN HEALTH, as provided above.

(b)    If Distributor so elects to extend the term for a subsequent 2-year period, prior to the end of the then-current term, Distributor and ZO SKIN HEALTH shall negotiate  to reach an agreement on Distributor' s Minimum Purchase Requirements for each year of the next 2-year period.  If they are unable to reach an agreement on Distributor’s Minimum Purchase Requirements prior to the end of the then-current term, the Minimum Purchase Requirement for each year of the subsequent 2-year period shall
be set  at    of  the  Minimum  Purchase  Requirement for  the  year  immediately
preceding that particular year.

(c)    If during any subsequent 2-year period, Distributor or its owners desire to sell  either  a  controlling  interest in the ownership of Distributor or substantially all of the assets  of  Distributor, Distributor must provide written notice of the transaction to ZO SKIN  HEALTH  within 30 days of date of that transaction and obtain ZO SKIN HEALTH’s consent to continue with this Agreement.  If Distributor fails to get ZO SKIN HEALTH’s consent, ZO SKIN HEALTH shall be entitled to terminate this Agreement.

8.2    Termination.    Either Party may specifically terminate this Agreement in the following circumstances:

(a)    If  either  Party  gives the other Party written notice to correct one or more breaches of the terms of this Agreement and the other Party fails to correct such breach  within  thirty  (30) days after receipt of written notice of the same,  the aggrieved Party may immediately terminate this Agreement. Notwithstanding the foregoing,  ZO SKIN HEALTH may terminate this Agreement without any advanced notice  and without providing an opportunity to cure for: (i) failure by Distributor to pay an invoice within 60 days of invoicing (as discussed in section 7.3); (ii) violation by Distributor of section 2.3 (“Sales Outside the Territory. Channels of Distribution; Internet Sales,” if ZO SKIN HEALTH determines that there is a pattern of violating that section; (iii) failure by Distributor to meet its minimum purchase requirements (as discussed in section 4.1); or  (iv) violation of the restrictions for use of the name "Obagi" as provided in section 4.7.  Waiver  by  ZO  SKIN  HEALTH  or  Distributor  of  a breach by the  other Party shall not constitute a waiver of any continuing breach or of any future breach by the other Party.

(b)    Either Party may immediately terminate this Agreement for cause upon giving  written  notice  of such termination to the other Party as a result of the occurrence of any of the following events:
			
	15

			
	Distribution Agreement ZO Medical-Int'l Form v. 4,0 • Cutera final-2

(i)    if the other Party makes a  voluntary petition in bankruptcy, insolvency or similar petition;

(ii)    an involuntary petition in bankruptcy, insolvency or similar petition is made against the other Party;

(iii)    if the other Party becomes insolvent or makes a general assignment for the benefit of creditors, suffers or permits an appointment of a receiver for its business or assets or is liquidated; or
(iv)    the  enactment  or adoption of any change in laws, rules, regulations or governmental policies or other change in circumstances that makes it illegal, impossible or impracticable to export, import, market, sell and distribute the Products to or in the Territory as contemplated in this Agreement.

8.3 Rights Upon Termination.  Upon termination  or  expiration of this Agreement:
(a) all of Distributor's rights granted hereunder shall immediately cease; (b) Distributor shall deliver to ZO SKIN HEALTH,  or at ZO SKIN HEALTH’s direction  shall destroy any and all  language  translations of ZO SKIN HEALTH’s sales and  technical  literature  and materials in Distributor's  possession  or  control, the costs of which shall be borne  by the Party whose breach of the Agreement caused the termination, if applicable, otherwise, such costs  shall  be borne by ZO SKIN HEALTH; (c) Distributor shall return to ZO SKIN HEALTH any Products or Related Products in its possession which were purchased from ZO SKIN HEALTH  within  one hundred twenty (120) days of the date of termination or expiration  of  the  Agreement, except for Products or Related Products required to fulfill legally binding Customer purchase agreements and quotations for a period of no longer than one hundred twenty (120) days from the date of termination or expiration; (d) Distributor shall immediately return to ZO SKIN HEALTH all other ZO SKIN HEALTH property, including, but not limited to, all original documents and copies which contain ZO SKIN HEALTH Proprietary Information; (e) Distributor shall deliver to ZO SKIN HEALTH such documents and instruments as ZO SKIN HEALTH may reasonably request in connection with the termination or expiration of this Agreement, but in no case shall this exceed the requirements of Section 4.2(h) above; and (f) Distributor shall remove from all of its facilities all signs, billboards and other similar items bearing any of the ZO SKIN HEALTH Marks or identifying Distributor as an authorized distributor of ZO SKIN HEALTH or the Products and Related Products and, within a reasonable period of time following such termination, withdraw or cancel any registrations or
filings  with  governmental  authorities  relating  to  Distributors’   use  of  any  of  the  ZO  SKIN
HEALTH Marks. It  is  agreed that  Products or  Related Products held by Distributor that were purchased  from ZO SKIN HEALTH  more than one hundred  twenty (120) days prior  to  the  date of  termination  shall be deemed “shelf worn” and of  no value.  ZO SKIN HEALTH  shall  promptly refund to Distributor the price Distributor paid for  the Products and  Related Products  returned  which  were purchased  within one hundred  twenty (120) days of termination. Except as required for Distributor's performance of obligations under this Section 8.3 or Section 8.4, upon expiration  or earlier termination of this Agreement, Distributor shall immediately cease and desist from any further use of Proprietary Information of ZO SKIN HEALTH. Surviving Terms.  The provisions of Sections 2.4, 7, 8.2, 8.3, 9, 10, 11, 12, 13, 14, 15 and 16  and  each other  provision  of  this Agreement,  which  by  its  nature survives
			
	Distribution Agreement ZOMedical – Int’lForm v 4.0• Cutera final-2

			
	16

expiration or termination, shall survive the expiration or the termination of this Agreement by either Party for any reason.

9.    ZO SKIN HEALTH'S WARRANTY AND INDEMNITY

9.1    Limited Warranties. Subject to Section 9.2, ZO SKIN HEALTH represents and warrants to Distributor that (a) ZO SKIN HEALTH has been duly incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation; (b) ZO SKIN HEALTH (and its authorized signatory) has the necessary corporate power, authority and legal capacity to enter into and to observe and perform its covenants and obligations under this Agreement  and has  taken  all  necessary corporate action in respect   thereof; (c) this Agreement has been duly executed and delivered by ZO SKIN HEALTH and constitutes ZO SKIN HEALTH's legal, enforceable and binding obligation; (d) ZO SKIN HEALTH’s execution and performance of this Agreement will not conflict with the terms or conditions of any other agreement or contract to which it is a party or is otherwise bound; (e) no approval, action or authorization by any governmental authority or agency is required for ZO SKIN HEALTH's execution and performance hereof (except for governmental certifications, registrations,
licenses and approvals for the export of the Products and Related Products to the Territory)
which has not already been obtained; (f) subject to any other provision in this Agreement to the contrary, ZO SKIN HEALTH owns all ZO SKIN HEALTH Marks and any patents, inventions, discoveries, know-how, confidential information, proprietary information and trade secrets, trademarks, service marks, internet domain names, copyrights and other copyrightable works, including, databases and software and all registrations and app1ications for registration of any of the  foregoing  (the “Intellectual Property”), related with the Products and Related Products or used or needed for the operation of the business of ZO SKIN HEALTH, or holds adequate
licenses or otherwise possesses sufficient rights to use such Intellectual Property in the United
States of America and the Territory; and, (g) all Products and Related :Products shall be of ZO
SKIN HEALTH standard quality..

9.2    Disclaimer of Warranties. EXCEPT AS PROVIDED IN SECTION 9.1 ABOVE, ZO SKIN HEALTH MAKES NO WARRANTIES, EITHER EXPRESS OR IMPLIED,  WITH REGARD TO THE PRODUCTS,  THE RELATED PRODUCTS OR THE ZO SKIN HEALTH MARKS, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT.

9.3    ZO SKIN BEALTH's Indemnification.

(a)    ZO SKIN HEALTH shall defend, indemnify and hold Distributor harmless from and against any claim of a third party that is either reduced to final, non-appealable judgment  or  settled  with  ZO  SKIN HEALTH's consent, not to be  unreasonably withheld,  to the extent arising from the gross negligence or willful misconduct of ZO SKIN HEALTH, its employees or agents (other than Distributor or sub-distributors of Distributor) in the performance of its obligations under this Agreement. ZO SKIN HEALTH  will  pay  resulting  court  costs,  damages  and  legal  fees finally  awarded,
provided Distributor promptly notifies ZO SKIN HEALTH in writing of any such claim,  ZO  SKIN  HEALTH   has  sole  control  of  the  defense  and  all  related
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 • Cutera final-2

			
	17

settlement negotiations, and Distributor provides ZO SKIN HEALTH with such assistance and all related information for such defense as ZO SKIN HEALTH may reasonably  request.  In the event ZO SIGN HEALTH assumes control of the defense of a matter,  it shall consult with Distributor on a regular basis and keep Distributor apprised of the status of the action.

(b)    ZO SKIN HEALTH shall defend, indemnify and hold Distributor harmless from  and  against any  claim that the Products,  ZO SKIN HEALTH technical and sales  literature  or  the  ZO SKIN HEALTH Marks infringe  in the Territory  on a patent,  trademark  or  copyright  of  a third party (a “Claim”), and  pay resulting court costs, direct damages and legal fees incurred in connection with such Claim, provided
(i)    Distributor promptly notifies ZO SKIN HEALTH in writing of any such Claim and
(ii)    gives  ZO  SKIN  HEALTH sole control of the defense of the same and  all negotiations  for  its  settlement  or  compromise.  Should  any  Products  or  Related Products become,  or in ZO SKIN HEALTH’s opinion be likely  to  become,  the  subject of  a  claim  of  infringement,  Distributor  shall  permit  ZO  SKIN  HEALTH,  at  ZO SKIN  HEALTH’s  option  and expense, to (x) procure for  Distributor  the  right  to continue  using the Products or Related Products, (y) replace or modify the Products or Related  Products  to  become non-infringing, or  (z) if neither procurement  nor replacement is commercially reasonable, terminate the sale of the Products or Related Products  or  terminate  this  Agreement by giving  written  notice  thereof  to  the Distributor, with no further obligation or liability to Distributor. Notwithstanding the foregoing,  ZO SKIN HEALTH  shall have no liability for any claim of  infringement  to the  extent  based upon  any modification of  the Products, ZO SKIN HEALTH technical and  sales  literature  or  of  the ZO SKIN HEALTH Marks not made  by  ZO SKIN HEALTH or  its authorized representatives with ZO SKIN HEALTH’s prior express written consent and, in no event shall ZO SKIN HEALTH have liability for any infringement until such time as ZO SKIN HEALTH receives actual notice of alleged infringement  and  then  the  liability shall only be for claims thereafter and only  in the event  ZO  SKIN HEALTH authorizes  in  writing the continuing  use of  the  same.   In the event  ZO SKIN HEALTH  does not authorize in writing the continuing use of the same,  any  affected  Products shall be considered Defective Products under  this Agreement. THE FOREGOING PROVISIONS OF THIS SECTION 9 STATE THE ENTIRE  LIABILITY  OF  ZO SKIN  HEALTH  WITH  RESPECT  TO INFRINGEMENT  IN  THE  TERRITORY OF  ANY  PROPERTY  RIGHT  OF  A THIRD PARTY BY THE PRODUCTS OR THE RELATED PRODUCTS, ZO
SKIN HEALTH TECHNICAL AND SALES LITERATURE AND THE ZO SKIN HEALTH MARKS.

10.    DISTRIBUTOR WARRANTY AND INDEMNITY

10.1    Limited Warranties.  Distributor  represents  and warrants  to ZO SKIN HEALTH that (a) Distributor has been duly incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation; (b) Distributor (and its authorized signatory) has the necessary corporate power, authority and legal capacity to enter into and to observe and perform its covenants and obligations under this Agreement and has taken all necessary corporate action in respect thereof; (c) Distributor has all required licensing, and is
			
	Distribution Agreement ZO Medical – Int’l Form v. 4,0 - Cutera final-2

			
	18

authorized, to sell pharmaceutical products in the Territory; (d) this Agreement has been duly executed and delivered by Distributor and constitutes Distributor’s legal, enforceable and binding obligations; (e) Distributor’s execution and performance of this Agreement will not conflict with the terms or conditions of any other agreement or contract to which Distributor is a party or is otherwise bound; and (f) no approval, action or authorization by any governmental authority or agency is required for Distributor’s execution and performance hereof (except for governmental certifications, registrations, licenses and approvals for the marketing, sale and distribution of the Products and Related Products in the Territory) which has not already been obtained.

10.2    Distributor's Indemnification. Distributor shall defend, indemnify and hold ZO SKIN HEALTH harmless from and against any claim of a third party that is either reduced to final, non-appealable judgment or settled with Distributor's consent, not to be unreasonably withheld, to the extent arising out of or resulting from:

(a)    Distributor’s   and   sub-distributors’   negligent    acts    or  omissions  or  willful misconduct in the use, import, marketing, promotion, advertising, distribution and  sale  of  the  Products or Related Products,  including but not limited to Distributor’s and sub-distributors’ promotional or advertising materials for the Products or Related Products;

(b)    Any statements, claims, representations or warranties made by Distributor or any sub-distributor relating to the Products or Related Products, other than as authorized or made by ZO SKIN HEALTH in writing, including but not limited to those made in the ZO SKIN HEALTH technical and sales literature and materials;
(c)    Any  breach  by Distributor and/or any sub-distributor of their obligations under this Agreement or a sub-distribution agreement; and

(d)    Any infringement or claim thereof of any patent, copyright, trademark, service mark, trade name, trade secret or any other property right of a third party arising from the use by Distributor or any sub-distributors of (i) any symbol, insignia, name or identifying characteristic other than the ZO SKIN HEALTH’s Marks, (ii) any combination of any ZO SKIN HEALTH Mark with any materials not provided or approved by ZO SKIN HEALTH, (iii)  any modification to the Products or Related Products not made by ZO SKIN HEALTH, or (iv) any use of the Products or Related Products not authorized or certified by ZO SKIN HEALTH or by the ZO SKIN HEALTH technical and sales literature and materials.

11.    LIMITATION OF LIABILITY.

11.1    DISTRIBUTOR  AGREES  THAT ZO SKIN  HEALTH'S  TOTAL AGGREGATE LIABILITY UNDER TIDS AGREEMENT SHALL NOT EXCEED THE AGGREGATE AMOUNTS PAID BY DISTRIBUTOR TO ZO SKIN HEALTH FOR PRODUCTS UNDER THIS AGREEMENT DURING THE IMMEDIATELY PRECEDING TWELVE (12) MONTHS OR, IN THE EVENT THIS AGREEMENT HAS BEEN IN EFFECT LESS THAN TWELVE (12) MONTHS, TWELVE (12) ANNUALIZED MONTHS FROM THE EFFECTIVE DATE.
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0 - Cutera final-2.

			
	19

11.2    IN  NO EVENT WILL ZO SKIN HEALTH BE LIABLE TO DISTRIBUTOR FOR CONSEQUENTIAL, EXEMPLARY, INCIDENTAL OR INDIRECT OR PUNITIVE DAMAGES OR LOSS OF GOODWILL, BUSINESS OPPORTUNITY OR PROFIT, IN CONNECTION  WITH THE  SUP PLY,  USE OR PERFORMANCE  OF THE  PRODUCTS
AND RELATED  PRODUCTS PROVIDED  HEREUNDER, OR IN CONNECTION  WITH
ANY   CLAI M  ARISING  FROM   OR  RELATED  TO THIS AGREEMENT,   EVEN  IF
DISTRIBUTOR  HAS BEEN ADVISED OF THE POSSIBILITY OF  SUCH DAMAGES  OR  IF THE EXCLUSIVE REMEDIES STATED HEREIN FAIL OF THEIR ESSENTIAL PURPOSE.

11.3    DISTRIBUTOR FURTHER AGREES THAT THE BENEFITS OF THIS SECTION 11 SHALL EQUALLY APPLY TO PERSONS OR ENTITIES RELATED TO ZO SKIN HEALTH, INCLUDING ITS PAST, CURRENT AND FUTURE EMPLOYEES, ATTORNEYS AND DISTRIBUTORS.

11.4    Notwithstanding  the  foregoing  provisions of this Section 11,  this  Agreement shall  not limit the liability of ZO SKIN HEALTH for personal injury, including death, arising from the gross negligence or willful misconduct of ZO SKIN HEALTH or its employees acting within  the  scope  of their employment, or  for  strict  product  Liability  to the extent the Parties are prohibited by applicable law from limiting ZO SKIN HEALTH’s responsibility therefor.
12.    PROPRIETARY RIGHTS.

Except as otherwise provided herein, ZO SKIN HEALTH expressly retains tit e and ownership to all  worldwide  Intellectual  Property rights, including without limitation, design,  know-how, patent  rights,  trademarks,  and copyrights in and to the Products or used in connection with Related Products, ZO SKIN HEALTH trademarks, service marks and logos, and any modifications, adaptations, derivative works, and enhancements made thereto.

13.    CONFIDENTIALITY.

13.1    Definitions. For purposes of this Agreement, “Trade Secrets” means information which:  (a) derives economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and (b) is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. “Confidential Information” means information, other than Trade Secrets. that is of value to its owner and is treated as confidential. “Proprietary Information” means Trade Secrets and Confidential Information.

13.2    Nondisclosure Requirements. Each Party agrees to hold Proprietary Information of  the  other Party in  strictest confidence and not to copy, reproduce, distribute,  manufacture, duplicate, reveal, report, publish, disclose, cause to be disclosed, or otherwise transfer the Proprietary  Information  of  the other Party to any third party, or utilize such Proprietary Information for any  purpose  whatsoever other  than as expressly contemplated  by this Agreement or  as  otherwise  agreed  to in writing  by the  Parties. Each Party may only disclose the other Party’s Proprietary Information to employees, representatives and consultants of such Party who are under a written obligation to comply with the nondisclosure obligations set forth herein. Each Party agrees to notify the other Party in writing of any suspected or known breach of the
			
	Distribution Agreement ZO Medical ~Int’l Form v. 4.0 – Cutera final-2

			
	20

obligations or restrictions set forth in this Section 13. The obligations of this Section 13.2 shall continue for so long as such information constitutes a Trade Secret under applicable law and for Confidential Information, for the term of this Agreement and for a period of three (3) years following termination or expiration of this Agreement. Notwithstanding the foregoing, any previously executed nondisclosure agreement between the Parties shall continue in full force and effect, provided that to the extent of any inconsistency or ambiguity between such non-disclosure
agreement and this Agreement, this Agreement shall take precedence and control and govern in all respects.    ·

13.3    Exceptions. The foregoing obligations of this Section 13 shall not apply if and to the extent that: (i) the information communicated was already known to a Party without obligation to keep such information confidential at the time of a Party's receipt from the other Party; (ii) the information communicated was received by a Party in good faith from a third party lawfully in possession thereof and having no obligation to keep such information confidential, or
(iii)    a  Party establishes that the information communicated was publicly known at the time of such Party’s receipt from the other Party or has become publicly known other than by a breach of this Agreement. If either Party is required to disclose all or part of the Proprietary Information of the  other  Party  pursuant  to  any legal requirement of any country which may have jurisdiction over that Party, such Party shall immediately upon becoming aware that such disclosure is required, give the other Party notice of the circumstances in which the disclosure is required and, subject to applicable law, agree with  the other Party on the extent and timing of such disclosure.
14.    TRADEMARKS

14.1    Use of the ZO SKIN HEALTH Marks.  ZO SKIN  HEALTH  hereby grants    to Distributor, and Distributor hereby accepts from ZO SKIN HEALIB, a nonexclusive, nontransferable , royalty-free license to use the ZO SKIN HEALTH Marks set forth on Exhibit C  hereto,  solely in connection with the marketing,  distribution,  promotion,  advertising  and sale  of  the  Products  and Related Products  in the  Territory and in accordance with any ZO SKIN HEALTH standards and instructions, and for no other purpose. ZO SKIN HEALTH may inspect and monitor Distributor's use of the ZO SKIN HEALTH Marks. Distributor shall not adopt,  use  or   register  any  words, phrases or symbols which are identical to or confusingly similar to any of  the ZO SKIN HEALTH Marks or oppose any such registration by ZO SKIN HEALTH. Distributor is not granted any right, title or interest in the ZO SKIN HEALTH Marks other than the foregoing limited license, and Distributor shall not use the ZO SKIN HEALTH Marks as part of Distributor's business entity or trade name or permit any third party to do so.

14.2    Markings.   Distributor  shall  not  remove or  alter  any ZO  SKIN  HEALTH trade  names, trademarks, copyright notices, serial numbers, labels, tags or other identifying marks, symbols or legends affixed to any Products or Related Products, documentation or containers  or  packages.  In  the  event re-labeling, insertion of legends  and/or  any  other regulatory modifications or insertions to labeling, tags or legends are required by Territory’s competent regulatory autbori6es, Distributor shall provide advance written notice of such requirements to ZO SKIN HEALTH and the Parties shall work together to satisfy those requirements.
			
	Distribution Agreement ZO Medical• Int’l Form v. 4,0 -Cutera flnal-2

			
	21

14.3    Infringements.  Distributor shall provide prompt notice to ZO  SKIN HEALTH of any infringement or potential infringement of the ZO SKIN HEALTH Marks by a  third  party and of any challenge to its use of the ZO SKIN HEALTH Marks by a third party. ZO  SKIN  HEALTH  reserves  the right  in  its  sole  discretion  to  institute. any  proceedings against third party infringers of the ZO SKIN HEALTH Marks, and Distributor shall refrain from  doing so.  Distributor shall cooperate fully with ZO SKIN HEALTH in any legal action taken  by  ZO SKIN HEALTH against such third parties, provided that ZO SIGN HEALTH shall pay all expenses of such action and all damages which may be awarded or agreed upon in settlement of such action shall accrue to ZO SKIN HEALTH.

14.4    Termination of Use. Except as otherwise provided in Section 8.3(c) hereof, upon termination of this Agreement, Distributor shall immediately cease any use of the ZO SKIN HEALTH Marks in any manner. In addition, Distributor hereby appoints ZO SKIN HEALTH its attorney in fact, which appointment is coupled with an interest, to allow ZO SKIN  HEALTH to cancel, revoke or withdraw any governmental registration or authorization permitting Distributor to use the ZO SKIN HEALTH Marks in the Territory. To effectuate the purposes of this provision, Distributor shall sign and deliver any documents and perform any further acts as may be reasonably requested by ZO SKIN HEALTH.

14.5    Distributor  Web Sites.   Notwithstanding anything  herein to the contrary1 Distributor shall not operate an Internet site that references any of the Products or Related Products  or  the  ZO SKIN HEALTH Marks ("Distributor Web Site" ) without the prior written consent of ZO SKIN HEALTH, not to be unreasonably withheld. In consideration of
ZO SKIN HEALTH allowing Distributor to reference the Products and Related Products or use the ZO SKIN HEALTH Marks in the Distributor Web Site, ZO SKIN HEALTH may provide and Distributor shall post upon mutual agreement on the Distributor Web Site within the Territory, mandatory content, including but not limited to privacy policies, terms of use, copyright and trademark notices, and graphics and trademark policies. Subject to ZO SKIN HEALTH’s prior written consent and upon mutual agreement, Distributor shall prominently provide on the home page of the Distributor Web Site within the Territory a link to ZO SKIN HEALTH’s Internet site in location, style, size and manner specified by ZO SKIN HEALTH.
14.6    Internet Search Strategies. Distributor may not use any ZO SKIN HEALTH Mark or any of the Products and Related Products in connection with any domain name, directory, address, locator, linking, co-branding, metatag, or with any other Internet search strategy.

15.    INSURANCE

15.1    Distributor Insurance. Distributor shall, at its own cost and expense, obtain and maintain in full force and effect the following insurance during the term of this Agreement:

(a)    Commercial and Umbrella / Excess General Liability insurance with per occurrence and general aggregate limits, combined, of not less than $1.000,000 per occurrence and in the aggregate;
			
	Distribution Agreement ZO Medical • Int’l Form v. 4.0· Cutera final-2

			
	22

(b)    Products and Completed Operations Liability Insurance with $1,000,000 each claim and general aggregate limits of not less than $5,000,000;

(c)    Workers' Compensation Insurance with statutory limits for Workers' Compensation to the extent required in the Distributor’s jurisdiction;

(d)    Distributor shall obtain a waiver from any insurance carrier with whom Distributor carries Workers’ Compensation insurance releasing its subrogation rights against ZO SIGN HEALTH.

(e)    Distributor shall furnish certificates of insurance for all of the above noted policies  as soon as practicable after the Effective Date and upon renewal or replacement of any such policies.  Each insurance policy that is required under this Section 15.1 shall be obtained from an insurance carrier with an A.M. Best rating of at least A-.

15.2    ZO SKIN BEALTH Insurance. ZO SKIN HEALTH shall, at its own cost and expense1 obtain and maintain in full force and effect the following insurance or program of self-insurance (provided ZO SKIN HEALTH maintains a financial condition reasonably sufficient to cover such commitments) during the term of this Agreement:

(a)    Commercial and Umbrella / Excess General Liability insurance with per occurrence and general aggregate limits, combined, of not less than $5,000,000 per occurrence and in the aggregate;

(b)    Products and Completed Operations Liability Insurance with per occurrence and general aggregate limits of not less than $5, 000,000;

(c)    Distributor shall be named as additional insured under the Commercial General Liability and Products and Completed Operations Liability insurance policies as respects  the  products and  completed operations  outlined  in this Agreement, subject to the limitations of those insurance policies.

ZO SKIN HEALTH shall furnish Distributor certificates of insurance for any policies obtained and which reflect that Distributor is an additional insured as soon as practicable after the Effective Date and upon renewal or replacement of any such policies. Any insurance policy that is obtained in satisfaction of this Section 15.2 shall be obtained from an insurance carrier with an A.M. Best rating of at least A-.

16.    MISCELLANEOUS.
16.1    Independent Contractors. Notwithstanding anything set forth herein to the contrary, the relationship of the Parties is that of independent contractors, and nothing herein shall be construed to create a partnership, joint venture, franchise, employment or agency relationship  between the Parties. Neither Party shall have authority to enter into agreements of any kind on behalf of the other Party and shall not have the power or authority to bind or obligate the other Party in any manner to any third party.
			
	Distribution Agreement ZO Medical – Int’l Form v. 4 ,0 - Cutera final-2

			
	23

16.2    Assignment. Neither Party shall assign or otherwise transfer including by operation of law its rights or obligations under this Agreement without the prior written consent of the other Party.

16.3    Force Majeure. Except for Distributor's obligation to pay under Section 7, neither  Party  shall be liable for any failure to perform or delay in performance of its obligations  hereunder  caused  by  circumstances  beyond its reasonable control, including, but not limited to,  fire, storm, flood,  earthquake,  explosion,  accident,  acts of a public  enemy or  rebellion, insurrection, riot, civil commotion, strikes or other labor disputes, sabotage, epidemic, quarantine or any agency thereof, judicial action, raw product shortages, and any other such external circumstances (a “ Force Majeure”).

16.4    Notices. Notices permitted or required to be given hereunder shall be deemed sufficient if given by (a) registered or certified  mail, postage prepaid,  return receipt requested,
(b) reliable private courier service, such as Federal Express, or (c) facsimile sent to the respective addresses  or  facsimile  numbers  and  to the attention of the representatives of the Parties set forth below or at  such other addresses or facsimile numbers or representative as the respective
Parties may designate by like notice from time to time. Notices so given shall be effective upon receipt by the Party to which notice is given.

To ZO SKIN HEALTH:

ZO Skin Health, Inc.
Attn: James R. Headley, President & CEO
1 Technology Drive, Suite B-123 Irvine, CA 92618
Fax: (949) 988-7544

With a copy to:

William P. Cates , Esq. Cates Peterson LLP
4100 Newport Place, Suite 230 Newport Beach, CA 92660 Fax: (949) 724-1190
To Distributor:

CUTERA, INC.
Attn: Rajesh Madan, Vice President of Finance and Legal 3240 Brisbane Blvd.,
Brisbane, CA 94005

Fax: (415) 715-3529
			
	Distribution Agreement ZO Medical- Int’l Form v. 4.0- Cutera fina1-2

			
	24

With a copy to:
CUTERA, K.K.
Attn: Chris West, Vice President Pacific Rim, Japan 12-10 Sakuragaoka-cho
Infoss Annex Bldg. 3F Shibuya-ku, Tokyo Japan 150-0031
Email: cwest@cutera.com
16.5    Arbitration. If any dispute arises between Distributor and ZO SKIN HEALTH relating to the subject matter of this Agreement, Distributor and ZO SKIN HEALTH shall each make a good faith effort to negotiate an amicable settlement of such matter. The Parties agree that, except as otherwise provided below, any disput,e, claim or controversy arising out of or relating in any way to the Parties’ relationship and/or to this Agreement or the breach, termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this Agreement to arbitrate, shall be determined by arbitration in Orange County, California, United States, before one arbitrator. The arbitration shall be administered by Judicial Arbitration and Mediation Services (“JAMS”) pursuant to its Comprehensive Arbitration Rules and Procedures. Judgment on the award may be entered in any court having jurisdiction. To the maximum extent possible, the existence, subject, evidence, proceedings, and ruling resulting from the arbitration proceedings shall be deemed confidential information, and shall not be disclosed by either Party, their representatives, or the arbitrator, except: (a) to the professional advisers of ZO SKIN HEALTH and Distributor; (b) in connection with a public offering of securities by ZO SKIN HEALTH or Distributor; (c) as ordered by any court of competent jurisdiction; or (d) as required to comply with any applicable governmental statute or regulation The arbitrator shall be required to prepare written findings of fact. Notwithstanding the foregoing, either Party may apply to a court of competent jurisdiction for a temporary restraining order, preliminary injunction or other equitable relief, as necessary in order to supplement  the  claims presented in the arbitration, without breach of this arbitration agreement and without abridgement of  the powers of  the  arbitrator.
16.6    Attorneys' Fees. If any Party brings an action or proceeding to enforce this Agreement or its rights under this Agreement, the Prevailing Party (as hereafter defined) in any such proceeding or action, or appeal thereon, shall be entitled to reasonable attorneys' fees and costs.  Such fees and costs may be awarded in the same action or proceeding or recovered in a separate action or proceeding, whether or not such action or proceeding is pursued to decision or judgment.  The term, “Prevailing Party” shall include, without limitation, a Party who substantially obtains or defeats the relief sought, as the case may be, whether by compromise, settlement, judgment., or the abandonment by the other Party of its claim or defense.

16.7    Governing Law. This Agreement has been made, executed and delivered in California, in which state the offices of ZO SKIN HEALTH are located. Accordingly, the Parties  invoke the laws of California regarding the protection of their rights and enforcement of their obligations hereunder and they mutually stipulate and agree that this Agreement is in all respects (including, but not limited to, all matters of interpretation, validity, performance and the consequences  of  breach) to be exclusively construed, governed and enforced in accordance with the internal laws (excluding all conflict of laws rules) of California and any applicable federal laws of the United States of America, as from time to time amended and in effect. The Parties agree that the United Nations Convention on Contracts for the International Sale of
			
	Distribution Agreement ZO Medical -Int’l Form v. 4.0 • Cutera final-2

			
	25

Goods shall not apply in any respect to this Agreement or the Parties.

16.8    No Solicitation of Related Personnel. During the term of this Agreement, and for a period of twenty four (24) months after termination of this Agreement, neither ZO SKIN HEALTH,  nor  Distributor , nor  any subsidiary or parent thereof,  shall,  directly  or indirectly, (i)  solicit for  employment or  consulting engagement,  (ii) offer employment to, or  (iii)  engage  the r elated  business services of any person who is or was an  officer, employee or consultant of the other Party.

16.9    Entire Agreement; Amendments; Severability. This Agreement constitutes the entire agreement between the Parties concerning the subject matter hereof, and supersedes and replaces all prior or contemporaneous understandings or agreements, written or oral, regarding such subject matter. No amendment to or modification of this Agreement, or any waiver of any term or condition of this Agreement will be binding unless in writing and signed by a duly authorized representative of both Parties. The section and subsection headings in this Agreement are inserted solely as a matter of convenience and for reference, and shall not be considered in the construction or interpretation of any provision hereof. If any provision hereof is declared invalid by a court or arbitral tribunal of competent jurisdiction, such provision shall be ineffective only to the extent of such invalidity, so that the remainder of that provision and all remaining provisions of this Agreement will continue in full force and effect.

16.10    Language. The official language of this Agreement is English. All contract interpretations, notices , and dispute resolutions shall be in English. Any amendments to this Agreement shall be in English. Translations of any of these documents shall not be construed as official or original versions of the documents, or otherwise referred to in the interpretation or construction of the intentions of the Parties hereto.

16.11    Interpretation. This Agreement has been negotiated between unrelated Parties who  are  sophisticated and knowledgeable in  the  matters  contained in this Agreement and who have acted in their own self-interest. In addition, each Party has been represented by experienced and knowledgeable legal counsel. Accordingly, any rule of law, including Section 1654 of the California Civil Code, as well as any other statute, law, ordinance, or common law principle, or other authority of any jurisdiction of similar effect, or legal decision that would require interpretation of any ambiguities in this Agreement against the Party who has drafted it is not applicable and is hereby waived. The provisions of this Agreement shall not be interpreted or construed  against  any Party  to this Agreement because that Party or any attorney or representative for that  Party drafted this Agreement or participated in the drafting of this Agreement.

16.12    Third Party Beneficiaries. Nothing herein express or implied is intended to or will be construed to confer upon or give any person or entity, other than the Parties, any rights or remedies under or by reason of this Agreement.

16.13    Public Announcements. Neither Party will make any press release or other public disclosure regarding this Agreement or the transactions contemplated hereby without the other  Party’s  express prior written consent, except as required under applicable law  or regulations, including SEC regulations, if applicable, or by any governmental agency, in which case the Party required to make the press release or public disclosure shall use commercially reasonable efforts to obtain the written approval of the other Party as to the form, nature and
			
	Distribution Agreement ZO Medical – Int’l Form v, 4.0 – Cutera final-2

			
	26

extent of the press release or public disclosure prior to issuing the press release or making the public disclosure.

16.14    Execution.  This  Agreement may be executed in any number of counterparts, each of which shall be deemed an original hereunder. Each Party agrees to be bound by its own facsimile or telecopy or PDF signature, and accepts the facsimile or telecopy or PDF signature of the other Party hereto.
Accepted and agreed on behalf of:

ZO SKIN HEALTH, .INC.    CUTERA, INC.

Name: Title:
			
	Distribution Agreement ZO Medical• Int’l Form v. 4.0 • Cutera final-2

			
	27

EXHIBIT A
TO THE DISTRIBUTION
AGREEMENT     BETWEEN
ZO SKIN HEALTH, INC.
AND
CUTERA, INC.

A.    PRODUCTS.

ZO SKIN HEALTH skin care products currently subject to this Distribution Agreement include:
SUGGESTED
DISTRIBUTOR    PRICE    SUGGESTED PURCHASE    TO        RETAIL
ITEM#    PRODUCT DESCRIPTION    SIZE    PRICE    CUSTOMERS    PRICE
050000    OilacleanseTM    240ml/8oz.
050100    NormacleanseTM    240ml/8oz.
050200    BalatoneTM    180ml/6oz.
			
	Distribution Agreement  ZO Medical – Int’l Form v. 4.0 • Cutera final-2

			
	28

051200     GlycogentTM    75ml/2.5oz.
050300     CebatrolTM (60 pads)    75ml/2.5oz.
050400    RetamaxThl    75ml/2 .5oz.
050500    Brightenex'"'    75ml/2.5oz. 051.600    ZO® Controlled Depth PeeTM'            NIA 080000    04rx MelaminTM (Rx only)        80g/2,8oz.
080100    08rx MelamixTM    (Rx only)    80g/2.8oz,
080200    Tretinoin 0.1%   (Rx only)    2091.7oz.
080300    Tretinoin0.05%  (Rx only)    20gl.7oz
051000     VitascrubTM     16291502.
051800    lnvisapeelTM    50ml/1 .7oz.
511000    HydrafirmTM    1591.5oz.
051400    AknetrolTM    60mll2oz.
520000    ZO®3-Step Stimulation PeelTM Kit    6 Peels
N/A    Oclipse® C SPF 50    120ml/4oz .
N/A    LipRebuildTM    15gl.5oz.

•    Conversion between milliliters and ounces is approximate.

B.    TERRITORY.
The Territory of Distributor shall be Japan, and any other geographic area designated by ZO SKIN HEALTII in writing and agreed to by Distributor for the exercise of Distributor's rights and obligations in the Distribution Agreement.
			
	Distribution Agreement  ZO Medical – Int’l Form v. 4.0 • Cutera final-2

			
	28

Exhibit A, Page 2

C.    DISTRIBUTOR'S MINIMUM PURCHASE REQUIREMENT
Distributor's Minimum Purchase  Requirements  of  Products  and  Related
			
	Distribution Agreement ZO Medical- Int’l Form v. 4.0 • Cutera final-2

			
	29

Products combined shall be 2015, to xxxxxx .in 2016, to

in 2014, and shall _increase to in 2017, and to xxxxx

in in 2018 (pro

rated for the short year). ZO SKIN HEALTH’S remedies on Distributor’s failure to meet the Minimum Purchase Requirements of Products and Related Products are set forth in Sections 4.1 and 8.1 of th.is Agreement. The above dollar amounts refer to United States currency.
			
	Distribution Agreement ZO Medical- Int’l Form v. 4.0 • Cutera final-2

			
	29

EXHIBITB

PURCHASE ORDER AND ROLLING FORECAST FORM
Rolling 4-Q Forecast by Units and Actual P.O Rolling 3-Q Forecast by Units
Distributor's Name: _ _ _ _ _ _ _ _ _ _ _ _  _  _

Distributor's Signature: _ _ _ _ _ _ _ _ _ _    Date: _ _ _ _ _ _ _ _ _ _

																																																												
		

QUARTER 1
		

QUARTER2
		

QUARTER 3
		

QUARTER4

	

' This Quarter represents a Purchase Order
	

UNIT
		

This Quarter is a Forecast Q2
	

UNIT
		

This Quarter is a Forecast Q3
	

UNlT
		

This Quarter is a ForecastQ4
	

UNIT

	

PRODUCTS
	

Oct. 12
	

Nov. 12
	

Dec, 12
	

Qtr. Total
		

Jan. 13
	

Feb. 13
	

Mar. 13
	

Qtr. Total
		

Apr. 13
	

May. 13
	

Jun_ 13
	

Q tr. Total
		

Jul. 13
	

Aug. 13
	

Sep . 13
	

Qtr. Total

																				
																				
																				
																				
																				
																				

(Note: This is just a sample spreadsheet in the format in which to layout your spreadsheet. Not all products are available in all countries. Please use only those products that are appropriate for your market.)
*The Quarter not shaded, signifies an actual Purchase Order and constitutes a binding order. The following three shaded quarters are viewed as forecasts Your signature above approves a shipment of product noted in Quarter one. Unit orders must be placed in master shipper quantities.
This order is subject to all the terms and conditions contained in your International Product Distribution Agreement.
This Form (Purchase order and Rolling 3-Q Forecast by units) must be provided to ZO SKIN HEALTH by February 1, by May 1, by August 1, and by November 1 of each year.
			
	Distribution   Agreement ZO Medical• Int'l Form, v. 4.0 • Cutera final•2.

			
	30

EXHIBITC

ZO SKIN HEALTH MARKS

ZO Skin Health has registered several trademarks with the United States Patent and Trademark Office with respect to its brand and products. They include:

•    "ZO”'®, registration no. 3443712
•    "Offects"®, registration no. 3818858
•    “Ossential"®, registration no. 3593734
•    "Ommerse”®, registration no. 3544801
•    "Oclipse"®, registration no. 3774720
•    "Olluminate"®, registration no. 3534953
•    "Oraser"®, registration no. 3534951

ZO Skin Health also has several other trademarks that it regularly uses in commerce. ZO Skin Health has trademark applications pending with the United States Patent and Trademark Office for the following trademarks:

•    "Balatone," application no. 85505883
•    " Brightenex," application no. 85505893
•    "Cebatrol," application no. 85505978
•    "Glycogent,'' application no. 85505981
•    " Melamin," application no. 85505963
•    " Melamix," application no. 85505965
•    " Normacleanse,'' application no. 85505878
•    "Oilacleanse," application no. 85505870
•    " Retamax," application no. 85505957;
•    " ZO Medical,'' application no. 85518544
•    "ZO Controlled Depth Peel," application no. 85505983

All of the above marks are collectively referred to as the “ZO trademarks.” ZO Skin Health actively uses and  markets all of the ZO Trademarks in commerce.
			
	Distribution Agreement ZO  Medical – Int’l Form v. 4.0 - Cutera final-2

			
	31

Exhibit C, Page 2

For purposes of Section 4.7, the phrase “by Zein Obagi, M.D.” may only be used in a font size not materially different than the proportional relationship to the font size of “ZO® MEDICAL” set forth below:

                                                               
			
	Distribution Agreement ZO Medical - Int'l Form v. 4.0- Cutera final-2

			
	32

			
	Distribution Agreement ZO Medical - Int'l Form v. 4.0- Cutera final-2

			
	32

EXHIBIT D

Defective Product Complaint

Below is the written procedure for reporting, processing and handling complaints regarding cosmetic products manufactured  by  or  for ZO SKIN HEALTH, Inc. (“ZO SKIN HEALTH”).  ZO  SKIN HEALTH may modify, remove, or replace these procedures at any time and from time to time by prior written notice to Distributor.

Upon receipt of a complaint by Distributor or a sub-distributor, the attached Product Complaint Form must be completed and fully identify the complaint and product(s) involved. The complaint must be submitted to ZO SKIN HEALTH's International Sales and Marketing Department, which receives all drug complaints. Whenever possible send the product associated with the complaint with the “Product Complaint Form.

The nature of the complaint must be classified as described below.

Quality Defect:
A  product  complaint expressing dissatisfaction with the quality of a product, e.g. a complaint expressing dissatisfaction with the attributes of the product, such as missing lot numbers or expiration dates, discoloration of product, leaking caps, etc.

Medical Defect (Adverse Experience):
A product complaint reporting an Adverse Experience associated with the use of the product with humans. An Adverse   Experience is  an event associated with the product, e.g. use of the product, any significant performance failure or unexpected pharmacological activity; such as rashes, hypo-pigmentation, acne, etc.
			
	Distribution Agreement ZO Medical- Int’l Form v. 4.0 – Cutera final-2

			
	33

COSMETIC PRODUCT      COMPLAINT FORM

			
	Distribution Agreement ZO Medical - Int'l Form v. 4.0- Cutera final-2

			
	34

EXHIBIT E

Sub-Distributor Agreement Requirements
►    All    terms defined in the Agreement shall be given the same meaning.
►    The    sub-distributor must be restricted  from directly or indirectly promoting, marketing, selling and
distributing the Products and Related Products through itself to Customers located in the Territory and
within the Channels of Distribution. This does not prevent Distributor from further restricting the rights
of sub-distributor with respect to the Products and Related Products.
Appoint ZO SKIN HEALTH a power of attorney, which appoint shall be coupled with an interest, for purposes of terminating the sub-distribution agreement as set forth below and in the Agreement.
Restrict sub-distributor’s use of  ZO SKIN HEALTH  sales and  technical  literature  and  materials to  the use required and approved by ZO SKIN HEALTH to exclusively promote, market, sell and distribute the Products and Related .Products in the Territory and within the Channels of Trade.
Reservation of all other rights related to the Products and Related Products to ZO SKIN HEALTH. Subject to the laws of Japan, restrict sub-distributor from selling Products and Related Products to Customers at a price below the suggested price to Customers set forth in the Agreement or allowing the sale of Products or Related Products to Customers who sell Products or Related Products to the public (i.e., end-user) at a price which is less than the retail price set forth in the Agreement. ZO SKIN HEALTH as attorney in fact shall have the right to terminate the sub-distribution agreement for any breach of these restrictions.
Require sub-distributor to use commercially reasonable efforts to further the promotion, marketing, sale and distribution of the Products and Related Products in the Territory and within the Channels of
Distribution, including but not limited to building brand awareness and participating in any ZO SKIN
HEALTH sales or promotional programs.
Require sub-distributor not to make any materially misleading or untrue statements concerning Products 
 and Related Products.
Restrict  sub-distributor  from selling, distributing, marketing, advertising or soliciting purchase orders for  any product that is competitively positioned to the Products or Related Products. Distributor shall have the right to immediately terminate sub-distributor for any breach of these restrictions. ZO SKIN HEALTH as  attorney in fact shall have the right to terminate  the sub-distribution agreement for  any breach of these restrictions. Notwithstanding the foregoing, if there is not a pattern of violations of this restriction,  as determined by ZO SKIN HEALTH, in its discretion, then Distributor shall have a period of 30 days to cure sub-distributor’s breach after receipt of written notice of such violation from ZO
SKIN HEALTH.
			
	Distribution Agreement ZO Medical· Int'l Form v. 4.0 • Cutera final-2

			
	35

Require sub-distributor to comply with all applicable Governmental Requirements and assist ZO SKIN HEALTH in obtaining any licenses, registrations or permits of any kind, and otherwise, to allow ZO
SKIN HEALTH to be in compliance with all Governmental Requirements in the Territory.
►    Restrict sub-distributor from using any marketing materials until receiving ZO SKJN HEALTH ' s written approval.
Require any return of Products or Related Products to be made through Distributor and not directly to
ZO SKIN HEALTH.
Require that the sub-distribution agreement be co-terminus with the Agreement.
			
	Distribution Agreement ZO Medical· Int'l Form v. 4.0 • Cutera final-2

			
	35

Require that upon termination or expiration of the sub-distribution agreement: (a) all of sub-distributor's rights granted thereunder shall  immediately cease;  (b) sub-distributor shall deliver to  Distributor any and all language translations of ZO SKIN REALTH’s sales and technical literature and materials in sub distributor’s possession or control; (c) sub-distributor shall immediately return to Distributor all other ZO SKIN HEALTH property, including, but not limited to, all original documents and copies which contain ZO SKIN HEALTH Proprietary Information; (e) sub-distributor shall remove from its facilities and other premises all signs, billboards and other similar items bearing any of the ZO SKIN HEALTH Marks or identifying sub-distributor as an authorized sub-distributor or distributor of ZO SKIN HEALTH or the Products and Related Products and, within a reasonable period of time following such termination, withdraw or cancel any registrations or filings with governmental authorities relating to sub-distributor's use of any of the ZO SKIN HEALTH Marks.  Except as required for sub-distributor’s performance of obligations under these requirements, upon expiration or earlier termination of the sub-distribution
agreement, sub-distributor shall immediately cease and desist from any further use of Proprietary Information of ZO SKIN HEALTH.
Restrict sub distributor's use and disclosure of ZO SKIN HEALTH'’s Proprietary Information to at least
the same extent as Distributor is restricted by the Agreement.
Restrict sub-distributor from operating an Internet side that references any of the Products or Related Products or the ZO SKIN HEALTH Marks without the prior written consent of ZO SKIN HEALTH, which shall also require sub-distributor to pose any information requested by ZO SKIN HEALTH with respect to the Productss,  Related Products or the ZO SKIN HEALTH Marks.
Restrict sub-distributor from using any ZO SKIN HEALTH Mark or any Products or Related Products in
connection with any domain name, directory, address, locator, linking, co-branding, metatag, or with any other Internet search strategy.
►    Make ZO SKIN HEALTH an express and intended third party beneficiary under the sub-distribution
agreement.
Any and all other requirements placed upon sub-distributors under the Agreement.
			
	Distribution Agreement ZO Medical – Int’l Form v. 4.0. Cutera final-2

			
	36

EXHIBIT F

Competing Products Subject to 2 Year Exception

1.    Elastilash (OMP product)

2.    Elastiderm (OMP product)

    

Distribution Agreement ZO Medical•lnt'l Form v. 4.0 - Cutera flnal-2    37

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]